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Abstract 
 
 
Gene expression during lytic development of bacteriophage Mu is regulated by a 
transcriptional cascade in three phases: early, middle and late. Transcription from the 
middle promoter Pm requires the 129-amino acid transcriptional activator Mor, a product 
of early transcription, and the Escherichia coli RNA polymerase. The Pm promoter has a 
recognizable -10 hexamer but lacks a -35 hexamer. Mor binds as a dimer to an imperfect 
dyad-symmetrical element containing two 6-bp inverted repeats and centered at -43.5 in 
Pm. The goals of this study were:  
 
1. To test the prediction from the crystal structure of Mor that residues Y70 and Q68 
of the β-strand whose side chains extend away from the protein, make base 
specific interactions in the DNA minor groove. 
2. To identify the bases between -30 and -57 of the promoter Pm that are important 
for its function, in terms of binding to His-Mor and transactivation with 
interactions with RNAP subunits, thus optimizing the Mor-binding sequence of 
Pm for crystal structure determination for a Mor-DNA duplex. 
3. To identify the critical number of bases of Pm required for the best binding of Mor 
and to test the stability of Mor binding to DNA probe containing Pm. 
 
To test the prediction of base specific interactions of the side chains of Y70 and 
Q68, mutagenesis of the 4-bp spacer region in the minor groove of the Mor-binding site 
using degenerate oligonucleotides were done to introduce all possible substitutions. Plate 
phenotyping on MacConkey agar plates was used to select Pm-lacZ clones that gave a 
defective phenotype indicated by white color. All the white ones had other mutations 
elsewhere in the plasmid and all the identified substitutions gave functional phenotypes 
as indicated by red color of colonies. This experiment revealed that the specific bases in 
the minor groove are not extremely important for interaction with the side chains of Y70 
and Q68 as they can tolerate mutations. But, gel shift and β-galactosidase expression data 
with a subset of these mutations indicated that the bases of the minor groove spacer 
region do play a modest role in His-Mor binding and activation of Pm as visible from 
their variations in the binding and tranactivation assay. 
 
Specific mutations were introduced in the Pm sequence from positions -30 through 
-57 upstream of the transcription start site to identify the critical bases for Mor-Pm 
interactions. Since Mor binds as a dimer to Pm, the mutations would indicate whether 
symmetry of the positions with respect to -43.5 or the specificity of the bases is what 
determines the importance of the bases at the respective positions. It would also help 
identify mutations that could increase Mor binding and positions that could contribute to 
interaction with RNAP subunits. Plate phenotyping, in vitro binding assay and in vivo β-
galactosidase assays were done for all the mutations. The 6-bp imperfect dyad-
symmetrical sequences flanking the minor groove spacer were found to be the most 
critical for Mor binding. Within the dyad-symmetry element, bases at positions -38 to -40 
and -47 to -49 are the most important as they do not tolerate any base changes. The 
region flanking the Mor-binding sites on either side does not seem to be critical for Mor 
 vi
binding, but the results indicate their function in transactivation, probably by influencing 
interactions of Mor with the RNAP subunits or conformational changes in the 
interactions at Mor-DNA-RNAP interfaces.  
  
 Two mutations, -46C alone and in combination with -50T, were specifically 
interesting as they bound to wild-type His-Mor more effectively than wild-type promoter, 
but displayed reduced in vivo activity. This observation led to the prediction that Mor 
also functions in promoter clearance and that higher binding of Mor to the promoter 
somehow negatively affects release of the core RNAP for transcription. This could mean 
that Mor has dual functions at the middle promoter: recruitment of RNAP and release of 
core RNAP during transcription initiation. Oligonucleotides with these specific mutations 
can be used for crystal structure determination for a Mor-DNA duplex as they stabilize 
the complex.    
  
 Different length oligonucleotides were used in gel shift assays with wild-type His-
Mor to identify the critical number of bases needed for efficient Mor binding. This 
experiment revealed that at least 20-bp, centered at -43.5, is needed for detectable binding 
to His-Mor. 
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Chapter 1: Introduction 
 
 
The central dogma of molecular biology is: DNA is transcribed to RNA which is 
translated to protein. Transcription is the process by which messenger RNA is made from 
the DNA using the anti-sense strand as the template. The sense strand of DNA has the 
codons for amino acid sequence of the protein that it codes for. In the subsequent step, 
mRNA is translated into amino acid sequence of the protein. Thus, transcription is the 
first important process by which the genetic information stored in the DNA is expressed 
(Figure 1). 
 
 
Transcription machinery 
 
DNA-dependent RNA polymerase is the key enzyme responsible for transcription 
in living cells. It catalyzes the formation of 5' - 3' phosphodiester bonds between 
ribonucleoside triphosphates. 
 
RNA polymerase can be divided into 2 evolutionary conserved groups based on 
the number of subunits constituting the enzyme; single-subunit RNA polymerases and 
multi-subunit RNA polymerases. Single subunit RNA polymerases are the simplest form 
of the enzyme in mitochondria and phages SP6 and T7 (McAllister and Raskin, 1993; 
Tunitskaya and Kochetkov, 2002). Prokaryotic and eukaryotic RNA polymerases are 
multi-subunit enzymes. Prokaryotic cells are characterized by one RNA polymerase, 
while eukaryotic cells have 3 different RNA polymerases: Pol I for rRNA synthesis, Pol 
II for mRNA synthesis and Pol III for tRNA synthesis (Cramer, 2002).  
 
Structural studies between the core subunits of eubacterial, archeal and eukaryotic 
RNA polymerases revealed that the homology of their amino acid sequences is extended 
to the structure and function of these proteins. They also show similarities in the relative 
position of the subunits, relative positions of the functional determinants, structural 
folding topologies of the subunits and in their mechanisms of interaction with DNA 
(Cramer, 2002). The most highly conserved regions are around the active center of the 
enzyme. This similarity decreases towards the outer part; this region is the target for 
transcriptional regulators (Ebright, 2000). The involvement of multiple subunits of Pol II 
and the larger size of pre-initiation complexes in eukaryotes pose a formidable challenge 
to dissect the key processes of eukaryotic transcription. Instead, the simple and highly 
similar bacterial RNA polymerase serves as an excellent model system in understanding 
the transcriptional machinery in general. 
 
The prokaryotic core RNAP consists of 5 subunits: α (2 copies), β, β' and ω 
(Figure 2). In association with the σ factor in a multistep and cooperative process, the 
core RNAP forms the holoenzyme (Borukhov and Nudler, 2003). The assembly pathway 
of the holoenzyme is represented as follows: 
α → α2 → α2β → α2ββ′ → α2ββ′ω (CORE) → α2ββ′ωσ (HOLOENZYME) 
(Ishihama, 1981; Ishihama, 1993). 
 2
 
 
Figure 1: The central dogma of biology.  
 
Transcription of DNA to RNA to protein.  
This dogma forms the backbone of molecular biology and is represented by three stages: 
 
1. Replication of DNA: The DNA replicates its information in a process that 
involves many enzymes. 
2. Transcription of the information from DNA to RNA: The DNA codes for the 
production of messenger RNA (mRNA) during transcription. In eucaryotic cells, 
the mRNA is processed (essentially by splicing) and migrates from the nucleus to 
the cytoplasm. 
3. Translation of the information from messenger RNA to protein sequence: 
Messenger RNA carries coded information to ribosomes. The ribosomes "read" 
this information and use it for protein synthesis. This process is called translation. 
 
Reprinted with permission from Access Excellence @ the National Health Museum 
http://www.accessexcellence.org/RC/VL/GG/central.php, Accessed June 18, 2008. 
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Figure 2: Representation of the holoenzyme of bacterial RNAP. 
 
The holoenzyme, with its subunits σ70, α (2 copies), β and β' are shown in the figure. 
The smallest subunit ω is not shown in the figure. The interaction interfaces between the 
various subunits are shown by arrows. 
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α 
α 
Interaction interface between σ, β and 
β’ subunits of the RNAP
Interaction interface between α and β’ 
subunits of the RNAP
Interaction interface between α and β 
subunits of the RNAP 
Interaction interface between σ and α 
subunits of the RNAP 
 4
σ subunit  
 
The σ factor, conferring promoter specificity, is directly responsible for promoter 
recognition and initiation of transcription. It is involved in the crucial process of 
conversion of the core enzyme into the holoenzyme during transcription initiation. It also 
functions in promoter melting, stabilization of the resulting single stranded DNA, binding 
of initiating nucleotide triphosphates and as a target for multiple transcriptional regulators 
(Li et al, 1994; Gross et al, 1998; Lonetto et al, 1998; Nickels et al, 2002; Dove et al, 
2003; Mitchell et al, 2007). In E.coli, there are different σ factors which recognize 
different promoters.Promoters of most of the genes involved in house-keeping function 
are recognized by σ70. Promoters of the genes involved in nitrogen metabolism are 
recognized by σ54, also called σN. Recognition of the promoters of the heat shock 
response genes is by σ32. Promoters of the genes for motility and chemotaxis are turned 
on by σ28. Promoter recognition of the stationary phase and stress response genes is 
controlled by σ38 (Ishihama, 2000; Grouse et al, 2006). Based on amino acid sequence 
comparisons of members of the σ70 family, it has 4 highly conserved regions, regions 
1.0-4.0 (Lonetto et al, 1992) which are the functional domains of σ subunit. These are 
further divided into sub-regions to which specific functions are assigned based on 
biochemical and genetic studies. These highly conserved regions of the σ subunit have 
specific functions that contribute to the subunit’s structure and function (Figure 3). 
 
Region 1.0: The self-inhibitory domain 1.1 of σ, is responsible for masking the DNA- 
binding regions of σ before it binds the core complex to form the holoenzyme 
(Dombroski et al, 1993). It was later shown that this region may bind the main channel of 
the core enzyme by widening the channel and enhancing the binding of DNA duplex 
(Bowers and Dombroski, 1999; Borukhov and Severinov, 2002). Region 1.2 along with 
2.1 and 2.2 is believed to create the hydrophobic interface for interaction with core 
enzyme. Recently, along with region 2.4, region 1.2 was also shown to be involved in 
promoter recognition of the -10 element (Zenkin et al, 2007). 
 
Region 2.0: Region 2.1 and 2.2 help form the holoenzyme by specifically interacting with 
the β' subunit (Sharp et al, 1999). Region 2.3-2.4 bind single stranded DNA in the 
formation of the open complex by promoter melting (Juang and Helmann, 1994) and 
interacts specifically with the -10 element of the promoter (Malhotra et al, 1996; 
Sevostyanova et al, 2007). 
 
Region 3.0: The subregions, 3.0-3.2 are implicated in promoter recognition, proper 
positioning of DNA-binding domains of σ, binding of nucleotides, abortive initiation and 
promoter clearance. Region 3.0 is involved in the recognition of the extended -10 
promoter element (TGn -10), which compensates for the absence of a -35 element in 
these promoters (Malhotra et al, 1996; Barne et al, 1997). Regions 3.1 and 3.2 form a 
loop called the σ3.2 loop as it is predominantly formed by region 3.2. The presence of 
this loop causes steric hindrance to the growing nascent transcript and is thought to be 
responsible for abortive initiation. The transcript needs to displace this loop in order to 
initiate elongation (Borukhov and Nudler, 2003; Murakami and Darst, 2003). 
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Figure 3: Representation of the different regions of the σ subunit of the RNAP with their 
functions.  
 
Modified with permission from Elsevier Limited. Murakami KS, Darst SA. Bacterial 
RNA polymerases: the wholo story. Curr Opin Struc Biol. 2003, 13(1): 31-9. 
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Region 4.0: Region 4.0 which is also called the σ-CTD plays a significant role in 
recognition of the -35 hexamer, interaction with the core enzyme, repositioning of  
DNA-binding domains of σ and activation of Class II activator dependent promoters 
(Campbell et al, 2002; Dove et al, 2003; Geszvain et al, 2004). Region 4.2 recognizes the 
-35 element of the promoters (Campbell et al, 2002). Conformational changes induced by 
σ 4.1 - β flap interactions reorient σ4.2 and σ2.4 such that σ4.2 is in a position to interact 
with -35 element of the promoters (Callaci et al, 1999; Kuznedelov et al, 2002). 
  
 
β and β' subunits  
 
The β and β' subunits form the catalytic center of the RNAP, forming the roof and 
the floor of the DNA tunnel respectively. Various regions of these subunits are 
specifically involved in interaction with α subunit, promoter melting, separation of the 
DNA:nascent RNA hybrid during elongation, closure of the main channel during 
elongation and formation of the secondary channel for entry of incoming nucleotides 
(Zhang et al, 1999; Vassylyev et al, 2002). 
 
 
α subunit 
 
The α subunit is a 329-amino acid protein which is folded into two domains that 
are connected by a 13-amino acid flexible linker. The two domains are the N-terminal 
domain (α-NTD; amino acid residues 1-235) and the C-terminal domain (α-CTD; amino 
acids 249-329). The dimerization of the 2 α-NTDs generates a platform for the assembly 
of the core complex. The N-terminal domain of the α subunit helps in the assembly of the 
β and β' subunits. It also plays a minor role as a target for catabolite activator protein 
(CAP) in some CAP-dependent Class II promoters (Ebright and Busby, 1995). The  
C-terminal domain of the α subunit can contact the upstream promoter region  
(UP-element) and can also interact with activator proteins (Ross et al, 1993; Busby and 
Ebright, 1994; 1995). The flexible linker can be 13 to 36 amino acids long and is thought 
to provide the flexibility for α-CTD to reach the UP-elements. The natural length of the 
linker is the most optimal for α-CTD-DNA interactions (Meng et al, 2001). 
 
 
ω subunit 
 
This is the smallest subunit of RNAP and consists of 90 amino acids. This subunit 
was in the past thought to be an impurity which tightly binds to RNAP. Deletion of the 
rpoZ gene encoding the ω subunit does not affect cell growth or activity of RNAP 
(Vassylyev et al, 2002). It is now clear that the ω subunit predominantly acts as a 
chaperone in folding of the β' subunit and its subsequent assembly into the α2ββ’ 
complex. It also participates in physical protection of the β' subunit, RNAP assembly and 
σ factor recruitment. It is also thought to play roles in mediation of the stringent response, 
transcriptional regulation, stress adaptation of RNAP and survival in stationary phase 
(Mathew and Chatterji, 2006). 
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Promoter architecture 
 
Promoters are the minimal DNA sequence elements located upstream of a 
transcription start site and provide a control point for regulated gene transcription. The 
promoter acts as a specific recognition site for RNAP and transcription factor proteins. 
Analysis of many E.coli promoters has revealed that there are 3 conserved promoter 
elements, characteristic of a typical eubacterial σ70 promoter (Hawley and McClure, 
1983) as represented in Figure 4:  
 
1. The -10 sequence: Also called Pribnow Box, it is centered approximately 10 base 
pairs upstream of the transcription start site, with a consensus sequence 5′ 
TATAAT 3′. 
2. The -35 sequence: Centered approximately 35 base pairs upstream of the 
transcription start site, with a consensus sequence 5′ TTGACA 3′. 
3. The spacer: It is typically located 17±1 base pairs between the two important 
promoter elements, -10 and -35 (Harley and Reynolds, 1987; deHaseth et al, 
1998). 
 
Thus, the consensus promoter architecture can be represented as follows: 
5’  TTGACA ---- 17±1 ---- TATAAT   3’. 
The strength of a promoter can be correlated to the degree of similarity of these promoter 
sequence elements to the consensus; the higher the similarity, stronger the promoter.  
   
Promoter recognition by the RNAP holoenzyme (Figure 5) is primarily achieved 
through interactions of σ2.4 with -10 hexamer and σ4.2 with -35 hexamer, though recent 
research has indicated the involvement of other regions of RNAP either directly or 
indirectly making these inteactions more complex. It has been shown that σ 1.2 can also 
play a significant role in the recognition of the -10 hexamer (Malhotra et al, 1996; 
Campbell et al, 2002; Murakami et al, 2002; Vassylyev et al, 2002; Zenkin et al, 2007). 
 
An additional class of promoters, called extended -10 promoters, is characterized 
by the presence of a TGn trinucleotide sequence immediately upstream of the -10 
hexamer and the absence of a recognizable -35 element (Keilty and Rosenberg, 1987). 
Recent research raises the possibility that a few more bases may play a role in these 
extended -10 promoters (Shultzaberger et al, 2007; Hook-Barnard et al, 2006). In the 
absence of a recognizable -35 element, the promoter activity is independent of 
interactions of σ4.2 with the -35 hexamer (Kumar et al, 1993), but is dependent on 
contacts between σ3.0 and the extended -10 sequence (Barne et al, 1997). 
 
A strong correlation between the strength of rrna P1 promoters and a 20-bp long 
AT-rich region located upstream of the -35 hexamer identified a new promoter element 
called the Upstream Promoter element (UP-element). This was defined as the promoter 
recognition element for the α-CTD of RNAP (Ross et al, 1993; Ross, 1993; Ross et al, 
1994; Ebright and Busby, 1995; Husnain and Thomas, 2008). The additional interaction 
of the α-CTD with the UP-element results in efficient recruitment of RNA polymerase to 
the promoter and contributes to the strength of the UP-element containing promoters  
 8
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Eubacterial σ70 promoter architecture and promoter elements.  
 
The DNA sequences from -60 to the +1 transcription start site are shown as a thick black 
line. The red bent arrow represents the +1 transcription start site and the rectangle boxes 
denote the specific elements of a bacterial promoter. Individual promoter elements are as 
written below their respective positions and the TGn motif represents the extended -10 
element. The consensus sequences for the -10 and -35 are given above their respective 
positions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
UP element -35  element TGn 
motif 
-10 element       +1  
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TATAAT 
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TTGACA 
concensus 
-60 
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Figure 5: RNA polymerase and its interactions at promoters.  
 
a) A model based on crystallographic studies of the initial docking of the RNA 
polymerase holoenzyme to a promoter. The DNA strands are shown in green, with the  
-10 and -35 elements highlighted in yellow and the TGn extended -10 and the UP 
elements highlighted in red. RNA polymerase is shown with the β and β′ subunits 
coloured light blue and pink, respectively, α-NTDs are coloured grey and the different 
domains of σ are coloured red. Grey spheres labelled I and II, represent the domains of  
α-CTD that bind to the promoter. The RNA polymerase active site is denoted by the 
Mg2+ ion, (magenta).  
 
b) A cartoon representation of the model of RNAP interaction at a bacterial promoter, 
illustrating the different interactions between promoter elements and the RNA 
polymerase. The consensus sequences for the -35 (TTGACA), extended -10 (TGn) and  
-10 (TATAAT) elements are shown. 
 
Reprinted with permission from Nature Publishing Group. Browning DF, Busby SJ. The 
regulation of bacterial transcription initiation. Nat Rev Microbiol. 2004, 2(1): 57-65.  
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(Aiyar et al, 1998; Gourse et al, 2000). This element has two subsites, proximal and 
distal, which function as binding sites for the two α-CTD’s (Estrem et al, 1999). 
 
 
Holoenzyme assembly 
 
Dimerization of α subunit is the first step in the assembly pathway, which 
provides a platform for the other subunits of the RNAP (β, β′, ω and σ) to assemble. 
Thus, α plays a critical role in the assembly of the core enzyme (reviewed by Ishihama, 
1981; Ishihama et al, 1987).  
 
The assembly pathway of the holoenzyme is represented as follows:  
α → α2 → α2β → α2ββ′ → α2ββ′ω (CORE) → α2ββ′ωσ (HOLOENZYME). 
 
Association of σ subunit to the core enzyme forms the holoenzyme complex. The 
type of σ factor associated with the core enzyme directs it to activate transcription from a 
specific promoter. Under normal growth conditions, σ70 associates with the core enzyme 
to direct transcription from the housekeeping genes. The type of σ factor to associate with 
the core enzyme depends on the cellular needs at that time. Alternative σ factors come to 
play during stressful or nutrient-depriving conditions. Occlusion of the core-binding 
determinants of σ by anti-sigma factors depending on environmental needs dictates the 
availability of the appropriate σ type for interactions with core RNAP (Mathee and 
Hughes, 1998; Campbell et al, 2003). The interactions between most of the σ factors and 
the core enzyme are similar and comparable. Interactions between σ1.2 and σ2.2 with the 
coiled coil element of β′ and of σ4.0 with the β-flap domain form the primary and 
secondary contacts respectively between σ and the core RNA polymerase (Borukhov and 
Severinov, 2002; Vassylyev et al, 2002; Murakami et al, 2002). 
 
 
Formation of closed promoter complex 
 
Binding of the core enzyme to the σ induces considerable conformational changes 
in the σ subunit that have important functional aspects. These conformational changes 
place the σ4.0 and σ2.0 in optimal places in the complex conferring on them the 
necessary specificity in terms of interactions with -35 and -10 elements of the promoter 
respectively (Callaci, 1999; Kuznedelov et al, 2002; Geszvain et al, 2004). These 
conformational changes in the RNAP holoenzyme also have functional implications in 
promoters with the extended -10 or the UP-element. Specific interactions between the 
σ2.4 and β facilitates opening of the main channel allowing entry of duplex DNA into it 
as shown in Figure 6 (Polyakov et al, 1995; Murakami and Darst, 2003). Transcriptional 
activators play a major important role in the recruitment of RNAP to the promoter 
through specific interactions with the RNAP subunits, primarily the more accessible  
α-CTD (Ebright and Busby, 1995). 
 
The role of DNA bending at this step of association of RNAP with the DNA in 
presence of activator is stoichiometrically important. DNA bending in some cases is a 
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consequence of the activator-DNA interactions while in others DNA bending facilitates 
protein-DNA interactions. This distortion of DNA is important for the complex protein-
protein and protein-DNA interactions at the promoter. The activators involved in DNA 
bending are called architectural activators as they influence the promoter architecture. 
Regulators of transcription through DNA bending sustain or inhibit the active promoter 
configuration to the effect that they can either activate or repress transcription depending 
on their effect (Perez-Martin and Espinosa, 1993; Perez-Martin and de Lorenzo, 1997).  
 
The regions 2.4 and 4.2 of σ subunit recognize the -10 and -35 promoter elements 
respectively relative to the transcription start site (+1). This forms the closed promoter 
complex which is in equilibrium with free RNAP and promoter DNA. The formation of 
this closed promoter complex is the first step in transcription initiation. It also involves 
other interactions (like the one between α-CTD and UP element) and active 
conformational changes at the promoter making it optimum for transcription. 
 
 
The transcription process 
 
There are three stages in the transcription process: initiation, elongation and 
termination. Biochemically distinct steps characterize the basic transcription cycle of 
E.coli RNAP. Transcription initiation can be further sub-divided into three stages: open 
promoter complex formation, abortive initiation and promoter escape (Borukhov and 
Severinov 2002). Promoter complex formation itself is a multi-step process involving 
binding of RNAP to the promoter forming the closed complex (RPc), transition from 
closed complex to transcriptionally competent open complex (RPo) with additional 
intermediate stages involving active conformational changes in the complex. The open 
complex is transcriptionally and enzymatically active. After a few abortive transcripts, 
promoter clearance allows the transition into transcription elongation during which RNA 
is made by adding nucleotide tri phosphates to the growing chain till the RNAP 
encounters the transcription stop site at which the transcription process is terminated. 
Thus, the process of RNA synthesis by RNAP requires that this protein has multiple 
functions either by itself or in concert with other proteins; it acts as a sequence-specific 
DNA-binding protein, then as a DNA strand-separation protein and finally as RNA 
synthetase. 
 
 
Promoter melting and formation of open complex 
 
The exposure of the template strand for transcription requires strand separation of 
the duplex DNA. The DNA duplex in the -10 region is typically melted from -11 to +3 
and includes the transcription start site +1 (Young et al, 2002). Region 2.3 of σ subunit 
stabilizes the initial transcription bubble extending downstream past the transcription start 
site to form the open promoter complex (Malhotra et al, 1996). In this position, and 
associated with significant conformational changes, the single stranded template strand is 
enclosed in an active site tunnel formed by the main channel (Figure 6). The downstream 
double stranded DNA from +5 to +12 from the transcription start site is enclosed by the β  
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Figure 6: Structural transitions during the steps of transcription initiation. 
 
Shown are cross-sectional views of the RNAP holoenzyme (β-flap, blue; σ, orange; rest 
of RNAP, gray; catalytic Mg2+, yellow sphere), promoter DNA (template strand, dark 
green; nontemplate strand, light green; −10 and −35 elements, yellow) and the RNA 
transcript (red) at the RPc (a), intermediate (I) (b), RPo and abortive initiation (c), end of 
abortive initiation (d), promoter clearance (e) and TEC (f) stages of transcription 
initiation. The view is looking down on top of the β subunit, but with most of β removed, 
revealing the inside of the RNAP active site channel.  
 
Reprinted with permission from Elsevier Limited. Murakami KS, Darst SA. Bacterial 
RNA polymerases: the wholo story. Curr Opin Struc Biol. 2003, 13(1): 31-9. 
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and β' subunits, stabilizing the complex. In the presence of nucleotides that enter the 
complex through a secondary channel and in association with σ3.0, transcription is 
initiated from the +1 transcription start site in the RNAP active site (Severinov et al, 
1994; Murakami et al, 2002).  
 
 
Abortive initiation 
 
The process of abortive initiation involves synthesis of a few short aborted 
transcripts, about 2-12 nucleotides long and their release from the complex in an 
unsuccessful attempt to continue transcription. The σ3.2 loop plays a major role in this 
process of abortive initiation. Two structural elements of σ3.2, a short helix and a long 
linker were identified to be the root cause for abortive initiation. The elongating RNA 
chain of 2-3 nucleotides encounters the short helix and this might cause the dissociation 
of transcript from the complex. Similarly, the σ3.2 loop is encountered by longer 
transcripts of 2-8 nucleotides on their way out of the complex (Vassylyev et al, 2002). At 
this juncture, if the RNA chain fails to displace the σ3.2 loop out of its way, this nascent 
transcript is cut by the RNAP and it dissociates from the complex. When the RNA chain 
elongates to about 12 nucleotides long, it is sufficient to fill the RNA-DNA hybrid and 
the upstream RNA channel completely under the β-flap, and it is now capable of 
displacing the σ3.2 loop. This ends the process of abortive transcription (Murakami and 
Darst, 2003). 
 
 
Promoter clearance 
 
This biochemical step drives the complex to initial stages of transcription 
elongation. During promoter escape, interactions between σ4.2 and the -35 element are 
destabilized. The RNAP can now leave the promoter and translocate downstream as RNA 
chain is elongated. The initial stage of transition into elongation does not require the 
complete dissociation of σ subunit, though eventually the σ factor is completely released 
from the complex, forming the ternary elongation complex with the core RNAP 
(Murakami and Darst, 2003). The formation of this elongation complex requires 
significant conformational changes in the complex. This ternary elongation complex has 
high processing ability to elongate the transcript. 
 
 
Transcription elongation 
 
During promoter clearance, the core enzyme leaves the promoter and enters the 
highly productive elongation phase of transcription. As the productive initial transcribing 
complex enters the elongation phase, σ70 is released from the promoter while the core 
enzyme continues transcription (Carpousis and Gralla, 1985; Krummel and Chamberlin, 
1989). This is diagrammatically represented in Figure 7. Translocation is proposed to 
involve scrunching of downstream DNA into the enzyme interior, generating strain that 
ultimately leads to the displacement of σ contacts on promoter DNA (Vo et al, 2003). 
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Figure 7: Structure-function model of the transcription elongation complex.  
 
(a) Structure of the nucleic acid scaffold of TEC. Five parts are distinguished: the 
upstream DNA duplex; the downstream DNA duplex; the 8-9 bp RNA-DNA hybrid; the 
single-stranded region of DNA in the transcription bubble; and the emergent ssRNA 
upstream of the hybrid. Filled circles represent DNA (template strand in red; nontemplate 
strand in yellow). The DNA-binding site is represented by a sliding clamp that encloses 9 
bp of the downstream DNA duplex. The hybrid binding site that accommodates the 
RNA-DNA heteroduplex is represented by two zip-locks that hold onto the edges of the 
heteroduplex and either zip or unzip the hybrid, maintaining its constant size during 
lateral movement of RNAP. The gray area represents the RNAP footprint.  
(b) Schematic model of TEC showing its main features. White lines show the 
correspondence between the functional and structural features of TEC. 
 
Reprinted with permission from Elsevier Limited. Korzheva N, Mustaev A. Transcription 
elongation complex: structure and function. Curr Opin Microbiol. 2001, 4(2): 119-25.  
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This results in the formation of a stable elongation complex in which the transcript is 
tightly bound in the RNA exit channel. The minimal elongation complex, a ternary 
complex, consists of the core RNAP bound to the DNA and nascent RNA, with many 
cooperative contacts increasing the complex stability (Borukhov et al, 2005). The process 
of RNA-DNA hybrid formation and subsequent RNA displacement from the template, 
and the mechanism of DNA translocation is a highly complex process involving 
tremendous structural and stoichiometric changes in the individual components of the 
machinery (Vassylyev et al, 2007). This process of transcription elongation is extremely 
complex as the RNAP goes through various conformational states for function and 
regulation (reviewed by Nudler, 1999; Erie, 2002). The earliest model proposed for 
elongation of transcript is called the inchworm model, according to which two distinct 
RNA and DNA-binding sites exist at the leadin and lagging edge of the active site of the 
polymerase (Uptain et al, 1997). The catalytic site for phosphodiester bond formation is 
at the lagging edge of the RNA binding site. RNA chain elongation proceeds in two 
phases; nucleotide addition and translocation. As nucleotide addition to the 3’-OH 
terminus continues, the leading edge is filled with the RNA transcript, conformational 
changes in the complex releases the template and transcript leading to translocation of the 
elongation complex (Krummel and Chamberlin, 1992; Uptain et al, 1997). The 
complexity of this process is enhanced by the fact that this could involve alternating 
phases of discontinuous (or inchworm-like) as well as monotonic movements of the 
polymerase.  
 
 
Transcription termination 
 
  Transcription in E.coli is terminated by two distinct mechanisms: Rho-dependent 
and Rho-independent. Rho-independent terminators are intrinsic terminators of inverted 
repeats coded in the DNA sequence followed by a stretch of A’s. The IR forms a hairpin 
in the RNA which pulls the stem bases away from the DNA template, leaving only the 
weak U-A pairs to maintain the DNA-RNA hybrid, thus releasing the RNA and making it 
fall off the DNA due to conformational changes in the RNAP. In Rho-dependent 
termination, the hexameric protein Rho binds to the nascent RNA of the transcription 
complex and releases it at defined Rho-dependent terminators along the template. Thus, 
at termination the RNA transcript is released from the elongation complex and 
conformational changes in the RNAP core release it from the DNA (Richardson, 1993; 
Ciampi et al, 2006; Banerjee et al, 2006). 
  
 
Transcription regulation 
 
Potentially, regulation of transcription can occur at any stage in the process, 
starting at initiation and continuing upto termination of transcription. Regulatory factors 
can function in enhancing or disrupting the various stages during transcription. Research 
in this field have identified and characterized the following regulatory elements in the 
process of transcription. 
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Regulation by σ factors  
 
The type of σ factor associated with the core enzyme directs it to activate 
transcription from a specific promoter. Under normal growth conditions, σ70 associates 
with the core enzyme to direct transcription from the housekeeping genes. The type of σ 
factor to associate with the core enzyme depends on the cellular needs at that time. 
Alternative σ factors come into play during stressful or nutrient-depriving conditions. 
Occlusion of the core-binding determinants of σ by anti-sigma factors depending on 
environmental needs dictates the availability of the appropriate σ type for interactions 
with core RNAP (Mathee and Hughes, 1998; Campbell et al, 2003). 
 
 
Regulation by small ligands  
 
Small ligands provide an alternative mechanism by which RNA polymerase can 
respond quickly and efficiently to the environment. The best example is guanosine 3', 5’ 
bisphosphate (ppGpp), which is synthesized when amino-acid availability is restricted to 
the extent that translation is also limited. The ppGpp ligand works by destabilizing open 
complexes at promoters. In fact, although the interaction of ppGpp with RNA polymerase 
is not promoter-specific, ppGpp-dependent inhibition occurs at promoters that control 
many of the genes that encode the protein products that are needed for translation. Many 
of these promoters recruit RNA polymerase very effectively and so, potentially, can 
initiate transcription at the maximum possible rate. However, to achieve these rates, the 
open complex must be stabilized and this requires higher ATP and lower ppGpp 
concentrations (Browning and Busby, 2004). 
 
  
Regulation by small RNAs  
 
The bacterial 6S RNA was the first sRNA shown to inhibit transcription by 
binding directly to the housekeeping holoenzyme form of RNA polymerase (σ70-RNA 
polymerase in E. coli) (reviewed by Wassarman, 2007). It resides within the active site of 
RNA polymerase and blocks access to promoter DNA. This 6S RNA regulation of 
transcription leads to altered cell survival, perhaps by redirecting resource utilization 
under nutrient-limiting conditions.  
 
 
Regulation by activators and repressors  
 
Based on the nature of regulation, positive regulators (those that turn the genes 
ON) are called activators and negative regulators (those that turn the genes OFF) are 
called repressors. Small molecules that cooperatively interact with activators are called 
inducers and those that interact with repressors are called co-repressors. Most of the 
positively controlled bacterial promoters lack one or more promoter elements due to 
which RNA polymerase is unable to bind to these promoters by itself. Activators that 
function at this step are sequence-specific DNA-binding proteins that bind to upstream 
 17
sequences in the promoter. Protein-protein interactions between activator proteins and 
RNAP subunits demands conformational changes to stereotypically accommodate the 
interactions (reviewed by Browning and Busby, 2004). Activators that act at the 
transcription initiation stage target the recruitment of RNAP to the promoter through 
interactions with various subunits of RNAP and could also mediate transition from closed 
complex to open complex by stabilizing the intermediate steps of isomerization (Dove et 
al, 2000). Based on the subunit of RNA polymerase it interacts with and the location of 
the binding site on the promoter, many activators are grouped into two classes, Class I 
and Class II. Class I activators have their binding site several bases upstream of the -35 
element even as far as -60 from the transcription start site and recruit the RNA 
polymerase through its interaction with α-CTD of RNAP. In contrast, Class II activators 
bind to promoters immediately upstream of or overlapping the -35 element and can affect 
multiple steps of initiation by its interaction with the α-CTD, α-NTD and/or C-terminal 
domain of the σ subunit of RNA polymerase. Activators can also function by altering the 
conformation of the target promoter to enable the interaction of RNAP with -10 and/or  
-35 promoter elements (reviewed by Browning and Busby, 2004). 
 
Most of the repressors act by binding to the promoter thereby preventing RNAP 
binding by steric hindrance, but they can also affect open complex formation and 
promoter clearance. Repressors can also function by looping of the promoter elements 
thereby preventing their interaction with RNAP. They can also function by modulation of 
functional domains of activator proteins thereby preventing their interaction with RNAP 
(reviewed by Browning and Busby, 2004). Initial stages of the RNAP binding to the 
promoters is the primary target for most repressors (Rojo, 1999; Rojo, 2001). All the 
classical repressors, LacI, PurR, TetR and TrpR are examples of repressors that act by 
binding to sequences within the promoter and block RNA polymerase binding to the 
promoter by steric hindrance. Repressors can also function by destabilization of open 
complexes leading to release of RNAP from the promoter or by stimulation of 
isomerisation. Most of the repressors that act at the promoter clearance step generally 
increase the affinity of RNA polymerase for the promoter, thereby preventing the release 
of the enzyme from the promoter (Rojo et al, 1998). Any stabilization of σ4.0/flap 
interaction might also result in stronger σ4.0/-35 contacts that prevent promoter clearance.  
 
 
Regulation by small molecules  
 
The secondary channel of RNA polymerase that transports NTPs to the active site 
is a target for a new class of regulators (Nickels and Hochschild, 2004). Microcin J25, a 
21-residue long peptide with antibiotic properties blocks the NTP entry by binding within 
the secondary channel (Adelman et al, 2004; Mukhopadhyay et al, 2004). DksA, a 
regulator of rRNA transcription also mediates regulation by binding within the secondary 
channel (Perederina et al, 2004). Structural studies of the multi-subunit RNAPs from 
bacterial and eukaryotic cells have illuminated the presence of large, solvent-accessible 
surfaces with numerous functionally crucial cavities and channels, the blocking of which 
would likely inhibit transcription. Among transcription factors that bind to bacterial RNA 
polymerase (RNAP) and modulate its activity, a number of small molecules irreversibly 
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inhibit RNAP thereby causing cell death (reviewed by Artsimovitch and Vassylyev, 
2006). Small molecule inhibitors such as rifampicin and sorangicin bind to the β subunit 
within the channel and act by directly blocking the path of the growing RNA chain 2-3 
nucleotides in length (Campbell et al, 2001; Campbell, 2005). Recent studies of the 
RNAP inhibitors indicate that although most of them possess unique mechanisms of 
action, they are unable to stop RNAP directly through steric hindrance, but rather utilize 
an indirect approach by limiting the access of the Mg2+ ions and substrates to the RNAP 
active site. Such indirect modulation of the RNAP catalytic center may in fact represent a 
common theme in transcription regulation (Artsimovitch et al, 2005; reviewed by 
Artsimovitch and Vassylyev, 2006; reviewed by Chopra, 2007). 
 
 
Bacteriophage Mu 
 
Bacteriophage Mu is a temperate bacteriophage of E. coli K-12 and also infects 
several other bacterial species like Citrobacter freundii, Klebsiella, Pseudomonas, 
Rhizobium and Alcaligenes eutrophus (reviewed by Symonds et al, 1987; Pato, 1990). It 
is a generalized transducing phage as well as the largest and the most efficient transposon 
(Harshey and Jayaram, 2006). Being a temperate phage, Mu has a regulatory circuit that 
functions as a switch between the lysogenic and lytic modes during its life cycle. Upon 
infection, a complex of phage proteins and the linear double-stranded 37-kb DNA 
genome, flanked by heterogenous host sequences, is injected into the host cell (Au et al, 
2006). The genome is then converted into a non-covalently closed form through the 
action of phage-encoded transposition proteins which binds to the ends of Mu DNA 
forming a protein-DNA complex that has been proposed to serve as an intermediate to 
integration into the host chromosome (Nakai et al, 2001). Through a random non-
replicative transposition mechanism, the phage genome is then integrated into the 
bacterial host chromosome, leading to duplication of the 5-bp target site which flanks the 
integrated copy of the Mu genome (Liebart et al, 1982; Chaconas et al, 1983; Sivan et al, 
1988).  
 
While a majority of the infected cells enter the lytic cycle, a fraction of the 
population becomes stable lysogens. Lysogeny is maintained by the repressor c, by 
binding to the early promoter, Pe and is stabilized by three host proteins: IHF (Integration 
host factor), H-NS (Histone-like nucleoid structuring protein) and FIS (Factor for 
inversion stimulation) (Betermier et al, 1993; Ranquet et al, 2005). Entry into the lytic 
cycle is marked by multiple rounds of replicative transposition and concomitant 
packaging into about 100 viral particles (Chaconas et al, 1981). Mu uses the host RNA 
polymerase with the primary sigma factor σ70 to transcribe its genes (Toussaint and 
Lecocq, 1974). Gene expression during the lytic cycle occurs in three phases: early, 
middle and late and is characterized by a highly controlled regulatory cascade (Marrs and 
Howe, 1990). The early genes are transcribed from the early promoter Pe, the middle 
genes from middle promoter Pm and the late genes from the late promoters Plys, PI, PP and 
Pmom (Margolin et al, 1989) (Figure 8). Thus, the lytic development of phage Mu presents 
an excellent model system to study the structural, mechanistic and functional aspects of 
both transposition and transcription activation. 
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Expression of the early operon from Pe is independent of de novo protein 
synthesis and phage replication and is stimulated by IHF (Wijffelman et al, 1974; Krause 
and Higgins, 1986; Marrs and Howe, 1990). The early promoter Pe has a good match to a 
typical E.coli promoter with recognizable -10 and -35 elements for recognition and 
binding by the bacterial RNAP (Krause and Higgins, 1986); it does not require the 
presence or function of an activator. Transcription from the early promoter can be 
detected within a few minutes of infection and induction (Wijffelman and van de Putte, 
1974) and results in the expression of early genes encoding proteins functioning in the 
lysis/lysogeny decision (Giphart-Gassler et al, 1981; Van Leerdam et al, 1982; Goosen  
and van de Putte, 1984; Krause and Higgins, 1984), the integration and replication 
functions A and B (Wijffelman and Lotterman, 1977; Toussaint et al, 1983), the Cro-like 
repressor Ner (van Leerdam et al, 1982) and a number of non-essential and  
growth-enhancing functions. This transcript also encodes the activator for Pm, the middle 
operon regulator Mor (Mathee and Howe, 1990). 
 
The middle and four late promoters have recognizable -10 hexamers, but lack 
sequences similar to the canonical -35 promoter element. Thus, they are subject to 
positive regulation by activator proteins (Figure 9). Transcription from these promoters 
depends on phage-encoded transcription activator proteins: Mor for Pm and C for the late 
promoters (Margolin et al, 1989; Mathee and Howe, 1990; Stoddard and Howe, 1990).  
 
Middle operon transcription initiating at Pm requires phage replication and the 
early gene product Mor. The middle transcript is detectable about 8 minutes into the lytic 
cycle and increases steadily thereafter (Stoddard and Howe, 1989; Marrs and Howe, 
1990; Stoddard and Howe, 1990; Mathee and Howe, 1990). Sequence analysis of the 
middle operon led to the prediction of five open reading frames with the most distal one 
encoding C, the activator of late transcription (Hattman et al, 1985; Heisig and Kahmann, 
1986; Margolin and Howe, 1986; Stoddard and Howe, 1987). With the exception of C, 
the other proteins encoded by the open reading frames of the middle operon do not seem 
to be important for phage development (Mathee and Howe, 1993). 
 
The genes of the late phase, expressed from the C-regulated late promoters (Plys, 
PI, PP and Pmom) encode functional components for phage morphogenesis, cell lysis and 
DNA modification. They are expressed about 20 minutes after induction and continue till 
lysis (Margolin et al, 1989; Stoddard and Howe, 1989). These promoters share an 
imperfectly conserved sequence overlapping the position of the absent -35 consensus 
hexamer (Stoddard and Howe, 1989; Margolin et al, 1989; Marrs and Howe, 1990).  
 
The roles of specific Mu late genes are as follows:   
 
1. The first gene of the late phase, lys, promotes cell lysis at the end of the lytic 
cycle (Faelen and Toussaint, 1973).   
2. Genes D-J as per their organizational positions on the Mu genome are required for 
phage head formation (Shore and Howe, 1982; Grundy and Howe, 1985). 
3. Genes K-W as per their positions on the genome, encode the structural and 
functional components of the tail assembly process (Grundy and Howe, 1985). 
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4. The host range for infection is specified by the products of the genes S, S’, U and 
U’ which are located within and overlapping the invertible G segment (Grundy 
and Howe, 1984). Different tail fiber proteins result from the two alternative 
arrangements of these genes, thus specifying adsorption to different 
lipopolysaccharide receptors (Sandulache et al, 1984) on the cell surface of either 
E.coli K12 or a heterogenous group of enteric bacteria (Kamp et al, 1978; van de 
Putte et al, 1980). 
5. The inversion of the G segment is catalyzed by the site-specific recombinase 
encoded by the gin gene (Kahmann et al, 1985). 
6. The mom gene encodes a DNA modification function which converts about 15% 
of all adenines to α-N-(9-β-D-2’-deoxyribofuranosylpurin-6-yl) glycinamide, 
which confers resistance of the infecting Mu DNA to cleavage by a wide range of 
restriction enzymes (reviewed by Kahmann, 1983; reviewed by Hattman, 1999). 
7. The com gene encodes the small zinc-coordinating translational activator of mom 
gene expression, Com (Wulczyn et al, 1989; Witkowski et al, 1995; Wulczyn and 
Kahmann, 1991). 
 
 
The middle promoter of bacteriophage Mu, Pm 
 
A strong basal promoter should ideally be close to the consensus sequence 
elements for efficient RNAP binding to initiate transcription. The region downstream of 
the -10 hexamer including the transcription start site should be prone to melting, and the 
upstream elements should contribute to RNAP binding. The importance of the spacer 
region is underscored by the fact that it should be of permissible length and show 
functional significance for productive RNAP binding, melting of the promoter region and 
conformational changes in RNAP required for efficient initiation. While some promoters 
in E. coli are active without the help of any accessory factors, many promoters need 
additional factors for function (Collado-Vides et al, 1991). The common feature of these 
promoters is the presence of a proximal site, usually between -20 and -70, facilitating the 
binding of activators specific for the promoters. Thus, it seems that the entire promoter 
region from about -70 to the transcription start site is functionally important contributing 
to various factors for productive transcription. Deletion and footprinting analyses in the 
promoter region revealed that sequences upstream of -62 and downstream of +10 are 
dispensable for promoter activity in terms of binding of Mor and RNAP although binding 
of the α-CTD to an UP-like element leads to increased levels of transcription (Ma and 
Howe, 2004). 
 
The initiation of transcription at Pm represents an important regulatory step in the 
production of viable phage progeny in the lytic. Transcription from Pm is dependent on 
phage replication, thus coordinating Mu DNA synthesis, the production of proteins for 
cell lysis and Mu genome packaging. The product of the middle operon, C protein 
triggers the expression of late genes which result in packaging of the Mu DNA into phage 
particles and cell lysis. The middle promoter Pm is a model promoter for positive 
regulation of transcription. It has a recognizable -10 hexamer, but lacks similarity to the 
consensus -35 hexamer. Initiation of transcription from this promoter depends on the 
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presence of RNAP holoenzyme and the phage-encoded activator Mor, both in vivo and in 
vitro (Mathee and Howe, 1990; 1993). Mutational analysis revealed that there are three 
regions important for promoter activity: 
 
1. The -10 region: involved in binding of the σ70 subunit of RNAP. 
2. An imperfect dyad symmetry element: DNase I footprinting analysis showed that 
Mor protects Pm sequences from -33 to -56 (Kahmeyer-Gabbe and Howe, 1996). 
An imperfect dyad symmetry element with a 6-bp spacer was identified between  
-36 and -51 (AGTAAagccggTTAAT). 
3. Region -29 to -31: between the Mor footprint and -10 region, which usually 
overlaps -35 consensus, has no similarity to the consensus. Both up and down 
mutations in this region had no detectable effect on Mor binding. DNase I 
footprinting with Mor resulted in hypersensitivity to cleavage between -29 and  
-32, indicating an alteration of DNA structure. Hypersensitivity to the  
single-strand specific agent potassium permanganate was also detected at -32 and 
-33 during simultaneous binding of Mor and RNAP holoenzyme. Thus, this 
region was hypothesized to undergo a conformational change during protein 
binding and promoter activation causing a distortion or unwinding necessary for 
precise alignment of Mor and RNAP (Artsimovitch and Howe, 1996). 
 
 
The middle operon regulator Mor 
 
The most distal ORF of the early operon encodes a small protein of molecular 
mass 14.7 kDa, which activates transcription from the middle promoter Pm; hence, it is 
called the Middle operon regulator protein Mor. It is the only Mu-encoded protein 
required for transcription of the middle operon both in vivo and in vitro (Mathee and 
Howe, 1990; 1993). It is a 129 amino acid , sequence-specific DNA-binding protein 
(Mathee and Howe 1990) with an isoelectric point of 6.3. The N-terminus of Mor is 
composed of a mixture of acidic and hydrophobic residues, whereas the C-terminal 
region is rich in basic residues, characteristic of a DNA-binding region. Mor is closely 
related and highly homologous to the C protein of bacteriophage Mu (about 31% 
sequence similarity) (Mathee and Howe, 1990) and they carry out similar functions. They 
are the founding members of a new family of transcription factors called the Mor/C 
family; they exhibit little or no homology to any other proteins except for Mor/C proteins 
in Mu-like prophages identified in bacterial genome sequences. Both proteins bind to 
DNA as dimers to a site located immediately upstream of the -35 region in their 
respective promoters. Consistent with their dimeric nature, an imperfect dyad symmetry 
element is present in the binding sites of both Mor and C. Like Mor, C protein also has an 
acidic and hydrophobic N-terminal region and a basic C-terminal region.  
 
The presence of an imperfect dyad symmetry element within the Mor-binding site 
(Artsimovitch and Howe, 1996) and the observation of dimeric species in glutaraldehyde 
cross-linking experiments suggested a dimeric nature for the protein. Mor binding 
introduces a distortion in the promoter DNA in the form of a bending angle of ~ 40° upon 
binding (Mo, 2004). Footprinting studies and mutational analysis of the middle promoter 
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identified the region from -36 to -51 of Pm as Mor binding site. The Mor binding site is 
characterized by the presence of 6-bp long AT-rich imperfect dyad symmetry element 
that is separated by a 4-bp long GC-rich spacer (Artsimovitch and Howe, 1996). Middle 
promoter activation by Mor requires the C-terminal domains of both alpha and sigma 
subunits of RNA polymerase (Artsimovitch et al, 1996). Experiments with purified Mor 
and α-CTD proved that Mor binding to Pm is strengthened by the addition of α-CTD and 
Mor might use its interaction with the α-CTD to recruit the RNA polymerase to the 
promoter through a synergistic stabilization of various protein-DNA interactions. 
Consistent with this, an UP-like element located 7-8 bp upstream of Mor binding site was 
identified as a binding site for the α-CTD of RNAP (Ma and Howe, 2004). Based on the 
above findings, a working model was proposed in which Mor binds to the promoter in a 
region centered at -43.5 and carries out transcription activation by recruiting RNA 
polymerase through its interaction with the C-terminal domains of the α and σ subunits of 
RNA polymerase (Figure 10) (Artsimovitch and Howe, 1996). 
 
Solving the crystal structure of Mor at a resolution of 2.2 Å was a landmark event, 
giving great insights into our understanding of the structural and functional significance 
of different regions of Mor with respect to Pm and RNAP interactions (Kumaraswami et 
al. 2004). The ribbon representation of the Mor dimer is shown in Figure 11. The crystal 
structure of Mor revealed that the Mor monomer is folded into two independent domains. 
The N-terminal domain is composed of two α-helices, α1 and α2, running in opposite 
directions with an angle of 120° to each other. The C-terminal domain contains three 
helices, α3, α4, and α5 folded into the Helix-turn-Helix (HTH) DNA-binding motif. The 
N- and C-terminal domains are connected by a β-strand linker (Figure 11). Three glycine 
residues (Gly65, Gly66, and Gly67) N-terminal to the β-strand and one glycine (Gly74) C-
terminal to it potentially create two flexible junctions between the N- and C-terminal 
domains. Helices α1 and α2 of the N-terminal domain and the β-strand, form the 
structural elements for Mor dimerization and are arranged with respect to the 2-fold 
symmetry-related axis to form an intertwined four-helix bundle with a pair of antiparallel 
β-strands capping one end of the bundle (Kumaraswami et al, 2004). At the Mor dimer 
interface, many hydrophobic residues, including leucines and isoleucines, interact with 
their symmetry-related equivalents in four layers of hydrophobic interactions forming an 
extensive hydrophobic core, thus stabilizing the dimer. The three helices, α3, α4, and α5, 
in the Mor C-terminus form a three-helix bundle with a classical helix-turn-helix  
DNA-binding motif. In Mor, helix α 3 serves the scaffolding role anchoring and 
stabilizing the other helices. Mor helices α 4, α 5 and the turn between them contain 
conserved residues characteristic of the DNA-binding HTH motif.  
 
Comparison of the structural elements with other HTH proteins provided evidence 
for an "ends-on" base recognition, with helix α5 serving as the Mor recognition helix 
(Kumaraswami et al, 2004). Modeling of the Mor-Pm interaction led to the prediction that 
Mor would bend the Pm sequence away from Mor. This can place the two adjacent major 
grooves of Pm in an optimum position to interact with the HTH domains of the Mor dimer 
at the two ends (Figure 12). Thus, conformational changes in both DNA and Mor are 
predicted to take place to achieve optimum structural and functional interactions 
(Kumaraswami et al, 2004).  
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Figure 10: Diagrammatic representation of protein-protein and protein-DNA interactions 
in the middle promoter open complex.  
 
Middle promoter is represented by the horizontal line. The dyad symmetry element for 
Mor binding is shown as inverted arrows; the spacer distortion from -34 to -32 by open 
diamond; the strand separartion in the open complex from -12 to +1 by an open oval. The 
black rectangles represent the interfaces of Mor-RNAP interactions. 
 
Reprinted with permission from American Society for Biochemistry and Molecular 
biology. Kumaraswami M, Howe MM, Park HW. Crystal structure of the Mor protein of 
bacteriophage Mu, a member of the Mor/C family of transcription activators. J Biol 
Chem. 2004, 279(16): 16581-90. 
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Figure 11: Ribbon representation of Mor dimer.  
 
It is viewed parallel to the crystallographic two-fold axis. One monomer is in yellow and 
the other in red. The secondary structure elements of the second monomer are identified 
with a prime. 
 
Reprinted with permission from American Society for Biochemistry and Molecular 
biology. Kumaraswami M, Howe MM, Park HW. Crystal structure of the Mor protein of 
bacteriophage Mu, a member of the Mor/C family of transcription activators. J Biol 
Chem. 2004, 279(16): 16581-90. 
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Figure 12: Proposed model for DNA-binding by Mor. 
 
The dimerization domains are represented as cylinders for α-helices and arrows for β-
strands. Mor HTH motifs are shown as ribbon representations. The arrows show the 
proposed interactions of the HTH motifs with the two adjacent major grooves. Panel B 
shows the DNA with a ∼40° bend as the HTH domains dock into the major grooves 
(Kumaraswami, 2005). 
 
Reprinted with permission from American Society for Biochemistry and Molecular 
biology. Kumaraswami M, Howe MM, Park HW. Crystal structure of the Mor protein of 
bacteriophage Mu, a member of the Mor/C family of transcription activators. J Biol 
Chem. 2004, 279(16): 16581-90. 
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Chapter 2: Mutational analysis of Pm and their possible 
effects on binding and activation by Mor 
 
Introduction 
 
 
Bacteriophage Mu is a temperate phage with its life cycle divided into two 
phases: lytic and lysogenic phases (Howe, 1973; Hattman, 1999). Transcription during 
the lytic cycle has a regulatory cascade composed of three phases of gene expression: 
early, middle and late (Marrs and Howe, 1990). Thus, the life cycle of phage Mu presents 
a valuable model system for studying transcriptional regulation (Howe, 1973; Hattman, 
1999). The early promoter Pe, has both -10 and -35 hexamers (Krause and Higgins, 
1986), a typical promoter architecture of  basal promoters. In contrast, the middle 
promoter Pm, and the four late promoters are model promoters for positive regulation; 
they have recognizable -10 hexamers but lack -35 hexamers  (Margolin et al, 1989; 
Stoddard and Howe, 1990). Transcription from these promoters requires phage-encoded 
activators. Transcription from Pm requires a product of the early transcript, Mor and 
transcription from the late promoters requires a product of the middle transcript, C 
(Margolin and Howe, 1990; Mathee and Howe, 1993).  
 
The middle operon regulator (Mor) protein is the product of the last gene in the 
early transcript and it is the only Mu protein required for transcription from the middle 
promoter Pm. Mor is a 129-amino acid long, dimeric, sequence-specific DNA-binding 
protein (Mathee and Howe, 1990; Kahmeyer-gabbe and Howe, 1996; Artsimocitch and 
Howe, 1996). Mor does not share amino acid sequence similarity with other families of 
transcription factors and,  together with the closely related phage-encoded activator C, 
defines a new family of transcription factors called the Mor/C family of transcription 
activators (Kumaraswami et al, 2004).  
 
The dimeric nature of Mor is supported by the following evidence: 
 
a) Extensive mutagenesis of the Mor-binding site in Pm revealed an imperfect dyad-
symmetry element with a central 4-bp spacer, suggesting the requirement of a 
dimeric form of Mor to recognize the symmetrical sequences (Artsimovitch and 
Howe, 1996).  
b) Glutaraldehyde cross-linking experiments identified a cross-linked species 
corresponding to the size of a Mor dimer (Artsimovitch and Howe, 1996). 
c) Mutational analysis of the Mu late promoter, Plys and SMCC cross-linking 
experiments with the Mu late gene activator C, a closely-related homologue of 
Mor, provided evidence for a dimeric form of C bound to a dyad-symmetrical 
binding site (Chiang and Howe, 1993; Ramesh and Nagaraja, 1996; Jiang, 1999; 
Zhao, 1999). 
d) The crystal structure of Mor captured the dimeric form of Mor through the two-
fold crystallographic symmetry axis (Figure 11) (Kumaraswami et al, 2004). 
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Mor recognizes and binds to a 16-bp region in Pm located at -36 to -51 bases 
upstream of the start site +1 (Artsimovitch and Howe, 1996). Mor activates transcription 
from Pm by recruiting the host RNA polymerase to the middle promoter (Mo, 2004). The 
basis for Mor-dependent Pm activation  include protein-protein interactions between Mor 
and the C-terminal domains of the α and σ subunits of RNA polymerase which are 
required for efficient recruitment of RNA polymerase to Pm (Artsimovitch et al, 1996; 
Ma and Howe, 2004; Mo, 2004).  
 
Mutational analysis of Pm revealed three important regions for its function:  
 
1. The -10 region which is important for Pm-σ interactions (Artsimovitch and Howe, 
1996). 
2. The 16-bp Mor-binding site located immediately upstream of the missing -35 
hexamer from -36 to -51. Extensive mutagenesis of Pm defined two AT-rich 5-bp 
long repeats in the imperfect dyad symmetry element that are separated by a  
 GC-rich 5-bp spacer (Artsimovitch and Howe, 1996). 
3. An UP-like element situated upstream of the Mor-binding site from -54 to -62 
comprising the binding element for the α-CTD of RNA polymerase (Ma and 
Howe, 2004). 
 
The crystal structure of His-tagged Mor at a resolution of 2.2 Å revealed a 
dimeric Mor protein with the two subunits being related to each other by a 
crystallographic two-fold symmetry axis. The first 26 amino acids of the N-terminus and 
the last 9 amino acids from the C-terminus were not visible in the structure. The Mor 
monomer is folded into two recognizable independent domains: an N-terminal 
dimerization domain and a C-terminal helix-turn-helix DNA-binding domain 
(Kumaraswami et al, 2004).  
 
The N-terminal domain is composed of two α-helices, α1 and α2. These two 
helices run in opposite directions with an angle of 120◦ relative to each other. The 
interlocking of N-terminal helices of both monomers against each other along with the 
anti-parallel interactions between the β-strands constitutes the dimerization domain. At 
the Mor dimer interface, many hydrophobic residues interact with their symmetry-related 
equivalents. Key residues involved in dimerization include several leucines of helix α1 
and a mixture of isoleucines and leucines of helix α2 (Kumaraswami et al, 2004). 
 
The C-terminal domain of Mor contains three helices, α3, α4 and α5, which are 
folded into the classic DNA-binding HTH motif. The specific positioning of the two 
HTH motifs at the opposite ends of the Mor dimer would structurally complement their 
interaction with the bases in the symmetry element. In Mor, helix α3 functions as the 
structural scaffold anchoring α4 and α5. The recognition helices α5, and the turn between 
α4 and α5 contain conserved residues characteristic of the DNA-binding HTH motif and 
structural coordinates similar to those of HTH proteins with an “ends-on” base 
recognition.  
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The N- and C-terminal domains are connected by a β-strand linker. Three glycine 
residues (G65, G66 and G67) are located in the loop N-terminal to the β-strand and one 
glycine (G74) is present in the C-terminal loop immediately after the β-strand, potentially 
creating two flexible junctions between the N- and C-terminal domains. Docking studies 
with a 16-bp B-DNA structure indicated that the two HTH motifs are located too far apart 
to interact with two adjacent major grooves in linear DNA. In order to overcome the 
calculated 9Å discrepancy, it was proposed that both protein and DNA might need to 
undergo conformational changes to allow Mor binding to DNA (Kumaraswami et al, 
2004). Consistent with this, a structural distortion with a 45° bending angle was observed 
in Pm upon Mor binding (Mo, 2004). The highly conserved glycines flanking the β-strand 
are hypothesized to be the pivot points for the conformational changes in Mor. 
 
Another interesting feature observed in His-Mor structure is the location and 
direction of the side chains of Y70 and Q68 in the β-strand region. These two side chains 
are protruding away from the molecule in upward direction and not involved in any intra 
or inter molecular interactions. In our current working model, in the presence of DNA, 
conformational changes originating from glycines (G65, G66, G67 and G74) place the N-
terminus of the recognition helix α5 in position to interact with the bases in the adjacent 
major grooves. This arrangement of protein and DNA would place the β-strand region 
under the minor groove of the central spacer between the 6-bp inverted repeats, such that 
the two residues Y70 and Q68 might interact with the minor groove of the spacer (Figure 
12). 
 
 
The current work 
 
Sequence-specific DNA-binding proteins read the information in DNA through 
the two structural features of a B-form DNA: major groove and minor groove. In most 
cases, the specific recognition of DNA takes place principally in the major groove due to 
its better accessibility and greater information content (Bewley et al, 1998; Jones et al, 
1999). The minor groove has a minor role in such interactions because of its narrower 
and deeper nature (Travers, 1995). Proteins with such dual binding mode generally have 
a HTH DNA-binding motif, which is used in major groove interactions (Jones et al, 
1999). 
 
The crystal structure of Mor identified two regions as possible candidates to make 
DNA contacts (Kumaraswami et al, 2004). The HTH motifs located in the C-terminal 
domain of Mor dimer are predicted to make interactions in the major groove of dyad 
symmetry element and the mutational analysis results were in agreement with the 
structural predictions. The HTH motif-major groove interactions place the β-strand linker 
region in the proximity of the minor groove of the spacer region located on the same face 
of the two major grooves.  
 
One remarkable feature of the β-strand linker region is the side chains of Q68 and 
Y70 that are protruding away Mor, but towards the possible direction of DNA indicating 
possibility of minor groove interactions (Figure 13). The primary sequence comparisons  
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A 
 
B 
 
Figure 13: Representation of Q68 and Y70 and possible Mor-DNA contacts.  
 
A) Representation of Q68 and Y70. The side chains of Q68 and Y70 from different 
monomers are color-coded (red from the dark gray monomer and green from the gray 
monomer). 
B) Possible Mor-DNA contacts. His-Mor dimer structure is as ribbons with the 
monomers in red and yellow; DNA in magenta. Green arrow represents the predicted 
Mor-minor groove interactions as a result of the Mor-major groove interactions which are 
shown as black arrows. 
 
Reprinted with permission from Kumaraswami M. Structural and functional 
characterization of Phage Mu Mor gene. 2005, University of Tennessee Health Science 
Center, Memphis. 
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of the amino acids in the β-strand linker region of the members of Mor/C family revealed 
a high degree of sequence homology at these two positions indicating the importance of 
those to Mor function and suggesting a common function in all the members. 
 
Comprehensive mutational analysis of Q68 and Y70 and inhibition assay with a 
GC-specific minor groove binding drug, chromomycin elucidated the important 
contribution of the residues (Kumaraswami, 2005). As in case of most of the transcription 
regulators, Mor needs to bind DNA in order to carry out transcription activation from Pm. 
The mutant proteins failed to activate transcription underlining the importance of  the 
side chains of Q68 and Y70 for Mor function, possibly by participating in the DNA-
binding function (Kumaraswami, 2005). Chromomycin inhibited Mor binding to 
promoter sequences at concentration as low as 2 μM indicating the importance of minor 
groove to Mor binding. Chromomycin was unable to completely disrupt the preformed 
Mor-DNA complex even at concentrations as high as 50 μM, thus, suggestive of  Mor-
minor groove interactions. The inhibition might be due to the disruption of Mor-minor 
groove contacts by chromomycin binding to the GC-rich spacer sequences or the 
structural effects extending into the flanking major grooves as a result of chromomycin 
binding to the minor groove. 
 
Protein-minor groove contacts have been classified into three major categories: 
intercalation, specific interactions and indirect readout. To gain access to the information  
content of narrower minor groove, protein pry open the minor groove by inserting the 
side chains of amino acids between adjacent bases by interdigitations which unstack the 
adjacent bases and introduce a kink or bend in the direction of the duplex DNA. In 
support of intercalation, a bending angle about 45˚ was observed in Pm upon Mor 
binding. Though the deficiency of chemical features presented by the minor groove is 
generally considered to be insufficient for specific recognition (Travers, 1995), some 
structures revealed specific contacts between different side chains and base edges 
exposed in the minor groove through hydrogen bonding, van der waals interactions, and 
water-mediated contacts (Moravek, 2002). In most cases it occurs in tandem with 
intercalation as it facilitates the specific interactions by wedging open the minor groove. 
Two pieces of evidence discounted the possibility of such specific interactions between 
Mor and the minor groove bases of the spacer region. First, single base substitutions 
identified in the spacer region of Pm appeared to be less detrimental to Mor binding 
compared to the mutations in the symmetry element. The tolerance to various mutations 
in the spacer region indicates the lesser role played by this region. Second, the conserved 
nature of Q68 and Y70 disfavors the specific contacts between identical side chains and 
chemically dissimilar spacer sequences of middle and four different late promoters. It is 
observed that amino acids that make specific contacts with different sequences are 
generally not conserved. It might be useful to test the effect of symmetrical substitutions 
in the spacer region on Mor binding. In indirect read-out, the conformational flexibility of 
the non-contacted bases in a protein binding site influences the affinity of a protein-DNA 
complex (Perez Martin J and de Lorenzo V, 1997; Mauro et al, 2003). Structural 
alterations in the DNA are crucial for the proper spatial relationship between the protein 
and DNA. Considering the high flexibility predicted for the GC-rich spacer region 
(Gabrielian and Pongor, 1996), indirect readout between Mor and the minor groove of the  
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spacer region is a possibility. It is possible that DNA oscillates between different 
conformations due to the flexibility conferred upon by the GC-rich spacer region and 
interactions between Mor and the minor groove sequences might trap the DNA in the 
bent conformation.  
 
Deletion mapping and DNase I footprinting revealed that Mor protects Pm 
sequences -33 to -56, thus indicating that Mor-binding sequence in Pm overlaps with this 
region (Kahmeyer-Gabbe and Howe, 1996). Thus, Mor binds to the promoter in a region 
centered at -43.5 and carries out transcription activation by recruiting RNA polymerase 
through its interaction with the C-terminal domains of the α and σ subunits of RNA 
polymerase (Artsimovitch and Howe, 1996; Ma, 2004). Also, previous mutational 
analysis of Pm identified two mutations upstream of the Mor-binding site, G-57T with 
twice the activity of the wild-type and A-54T with half the wild-type activity, suggesting 
that sequences upstream might play a role in Pm function (Artschimovitch, 1996). 
 
The goal of this study is to study the effect of mutations in Pm from -30 to -57 
spanning the region previously shown to be important for Mor- Pm interactions. This 
would also help us to optimize the Mor-binding region of Pm useful for crystallographic 
studies of Mor-DNA duplex. Extensive mutagenesis studies were also conducted to study 
the effect of mutations in the spacer region of -42 to -45 because this is the spacer region 
in which the side chains of Y70 and Q68 from the β-strand protrude into. This was done 
to test if Mor-DNA interactions in the minor groove occurred through specific base 
contacts. In addition to the extensive mutatgenesis of the spacer region, targeted 
mutagenesis was carried out for the entire region with specific mutations chosen for each 
position as given in Table 1. The rationale behind each of the specific mutation is 
discussed in the Table 2. 
 
For the spacer region, mutagenesis was done with degenerate oligonucleotides for 
the 4 positions in pair and as a group. Plate phenotyping of the mutants, gel shift assays 
for the mutants with wild-type His-Mor and β-galactosidase assays were used to 
differentiate the effect of the mutations. Gel mobility shift assays were done with 
oligonucleotide probes. The length of the oligonucleotide probe needed for efficient Mor 
binding was first standardized and various mutations were then introduced into the 
specific length probe. 
 
The center of the Mor-binding site in Pm is -43.5 position between -43 and -44 
from the transcription start site of +1. The mutations that we made either introduced 
symmetrical changes in positions that were not symmetrical centered at -43.5 or disrupted 
the symmetry by introducing a different base. The symmetrical changes refer to positions 
the same number of bases from the center of -43.5. As Mor binds Pm as a dimer, these 
mutations would help us study the effect of symmetry element for binding of the dimer. 
They would also help us study the contribution of the specific bases for Mor binding. The 
contribution of the bases to the stability of Mor-Promoter duplex can be studied by 
mutagenesis of this region of Pm. 
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Table 1: Specific mutations of the promoter.  
 
A comprehensive table which gives all the mutations that were done for Pm spanning the 
region from -57 to -30 with respect to the transcriptional start site of +1. The second row 
gives the bases in the wild-type sequence of Pm and their positions are numbered above 
them. Following that, the 29 mutations are given sequentially. The mutation numbers are 
in the first column and the letters in red are the mutations that were introduced at that 
position. The unfilled boxes indicate that the bases in these positions are same as that in 
the wild-type promoter. The blue underlined bases indicate the dyad-symmetry element 
predicted to interact with Mor in the major groove. The purple letters indicate the 
position of the bases of the minor groove spacer region. 
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Table 2: Mutations of Pm and the rationale behind each of them. 
 
Mutation 
numbers 
Mutation Rationale behind the mutation 
 
Mutation 1 -46 A to C To make symmetrical* substitution 
corresponding to -41G. 
Mutation 2 -41 G to T To make symmetrical substitution 
corresponding to -46A. 
Mutation 3 -48 A to C and -39 T to G To maintain symmetry, but with a GC 
combination at these positions. To test if 
specific bases are important or is it just a 
factor of symmetry. 
Mutation 4 -37 A to C To make symmetrical substitution 
corresponding to -50G. Previous data** 
recorded slightly higher in vivo activation 
as compared to wild-type. 
Mutation 5 -52 C to G To make symmetrical substitution 
corresponding to -35C. 
Mutation 6 -52 C to A and -35 C to T To make these positions symmetrical with 
respect to each other with an AT 
combination. Previous data for -35 C to T 
recorded slightly higher in vivo activation 
as compared to wild-type. 
Mutation 7 -34 C to T To make symmetrical substitution 
corresponding to -53A. Previous data 
recorded slightly higher in vivo activation 
as compared to wild-type. 
Mutation 8 -53 A to G To make symmetrical substitution 
corresponding to -34C. Previous data 
recorded slightly higher in vivo activation 
as compared to wild-type. 
Mutation 9 -33 G to T To make symmetrical substitution 
corresponding to -54A. Previous data 
recorded slightly higher in vivo activation 
as compared to wild-type. 
Mutation 10 -54 A to C To make symmetrical substitution 
corresponding to -33G 
Mutation 11 -32 G to T To make symmetrical substitution 
corresponding to -55A. Previous data 
recorded slightly higher in vivo activation 
as compared to wild-type. 
Mutation 12 -31 C to A To make symmetrical substitution 
corresponding to -56T. Previous data 
recorded twice the wild-type activity. 
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Table 2 (continued). 
 
Mutation 
numbers 
Mutation Rationale behind the mutation 
 
Mutation 13 -56 T to A and -31 C to T To maintain the symmetry of mutation 12 
but by swapping positions of A and T. 
substitution at -31 gave twice the wild-type 
activity as compared to wild-type. 
Mutation 14 -57 G to T Previous data revealed twice the activity as 
compared to wild-type sequence. 
Mutation 15 -57 G to T and -30 T to A Previous data of substitution at -57 
revealed twice the activity as compared to 
wild-type sequence. To make symmetrical 
substitution corresponding to -57 when 
changed to T. 
Mutation 16 -50 G to T and -41 G to T To make symmetrical substitutions at both 
positions corresponding to -37A and -46A 
respectively such that the 6 base-pair dyad 
symmetry is perfect and AT-rich. 
Mutation 17 -50 G to T and -46 A to C To make symmetrical substitutions at both 
positions corresponding to -37A and -41G 
respectively such that the 6 base-pair dyad 
symmetry is perfect and AT-rich except at 
positions -41 and -46, where it is GC-rich. 
Mutation 18 -42 through -45 AAAA Making these positions A-rich to test if this 
mutation makes any change in the minor 
groove dimensions that could affect Mor 
binding or is it just the specific bases that 
are important in the minor groove spacer. 
Mutation 19 -42 through -45 TAAT Making these positions AT-rich, but 
maintaining the wild-type symmetry. To 
test if this mutation makes any change in 
the minor groove dimensions that could 
affect Mor binding. 
Mutation 20 -42 through -45 GGCC Making the spacer region symmetrical 
centered at -43.5. 
Mutation 21 -42 through -45 GGGG Making it G-rich to test if specific bases are 
important in the minor groove or is it just 
the minor groove dimensions. 
Mutation 22 -57 G to T, -53 A to G 
and -31 C to T 
Previous data with the specific substitutions 
at the 3 positions gave twice the wild-type 
activity. To test if these substitutions 
together are cumulative in their effect or 
otherwise. 
Mutation 23 -57 G to T and -53 A to G A subset of mutation 22 with the same 
rationale. 
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Table 2 (continued). 
 
Mutation 
numbers 
Mutation Rationale behind the mutation 
 
Mutation 24 -57 G to T and -31 C to T A subset of mutation 22 with the same 
rationale. 
Mutation 25 -53 A to G and -31 C to T A subset of mutation 22 with the same 
rationale. 
Mutation 26 -50 G to T To test the individual contribution by -50T 
from mutation 17, as mutation 17 gave 
twice the wild-type binding by His-Mor in 
a gel shift in vitro binding assay. 
Mutation 27 -48 A to T and -39 T to A To maintain symmetry at these positions 
with respect to each other but by swapping 
the bases from wild-type sequence to test if 
binding by wild-type His-Mor is affected 
by symmetry or the specific bases in these 
positions. 
Mutation 28 -49 to -47 ATT and 
-40 to -38 AAT 
To maintain symmetry at these positions 
with respect to each other but by swapping 
the bases from wild-type sequence to test if 
binding by wild-type His-Mor is affected 
by symmetry or the specific bases in these 
positions. 
Mutation 29 -50 to -46 TATTC and 
-40 to -38 AAT 
To test effect of mutation 28 in 
combination with mutation 17 (gave twice 
the wild-type promoter binding by His-Mor 
in the gel shift assay). 
 
 
* Symmetry centered at -43.5. 
** Previous data - Artsimovitch, 1996. 
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Materials and methods 
 
 
Media, chemicals and enzymes 
 
 Protein over-expression and routine cell growth were done in LB medium 
(Howe, 1973), whereas cultures for β-galactosidase assays were grown in minimal 
medium with casamino acids (M9CA) (Margolin et al, 1989). Bacto agar, Bacto tryptone 
and Bacto yeast extract used for LB medium were purchased from Difco Laboratories 
and sodium chloride from Fisher Scientific. MacConkey lactose plates with 25 g/L of 
MacConkey agar (Difco) and 25 g/L of MacConkey agar base (Difco) was used for plate 
phenotyping. Chloramphenicol and ampicillin were purchased from Sigma. Isopropyl-β-
D-thiogalacto-pyranoside (IPTG) was from US Biologicals and o-nitrophenyl-β-
galactopyranoside (ONPG) was from American Bioorganics. Acrylamide, bisacrylamide, 
40% acrylamide/bis-acrylamide (29:1) solution, tetramethylethylenediamine (TEMED) 
and ammonium persulfate (APS)were purchased from BioRad. Chloroform and glycerol 
were obtained from Fisher Scientific. Imidazole was purchased from Sigma and sodium 
dodecyl sulfate (SDS) was from BioRad. Trizma base was from Sigma. Glacial acetic 
acid, ethylene diamine tetraacetic acid (EDTA) and boric acid were purchased from 
Fisher Scientific. D-Glucose, M9 salts, thiamine, biotin, potassium chloride, 
dithiothreitol, IGEPAL CA-630 and Ficoll-400 were all purchased from Sigma. Glycine 
and β-mercaptoethanol were from BioRad. Casamino acids was from Difco and sodium 
carbonate was from JT Baker. Magnesium sulfate, calcium chloride, monosodium and 
disodium phosphates were from Sigma. Absolute ethanol and 95% ethanol were from 
AAPER Alcohol and Chemical Co., Shelbyville, KY. Seakem ME and LE grade agarose 
were from Lonza, Rockland Inc. The bradford protein assay reagent and Bio-safe 
Coomassie stain for protein gels were from BioRad. Dimethyl sulfoxide (DMSO) for 
freezing the bacterial strains was from Sigma. The restriction enzymes BamH1 and 
EcoR1 were from New England Biolabs. Taq polymerase was from Roche Diagnostics 
and T4 DNA ligase was from New England Biolabs. T4 polynucleotide kinase (PNK) 
and dNTPs were obtained from Promega Corporation. Shrimp alkaline phosphatase 
(SAP) was purchased from Roche Diagnostics. [γ P32]-ATP was obtained from Perkin 
Elmer Life Science, Boston, MA. Talon spin columns used for protein purification were 
from Clontech. Miniprep and midiprep kits for small and large scale plasmid extraction 
respectively were purchased from Promega Corporation. Kit for purification of PCR 
products was obtained from Qiagen. Slide-A-Lyzer dailysis cassette (10-kDa cutoff) for 
protein purification was from Pierce. Columns for purification of oligo probes used in gel 
shifts, G25 (for oligonucleotides from 10-20 bases in length) and G50 (for 
oligonucleotides 20-50 bases in length) were from GE Healthare. BioMax MR films for 
exposing the gel shift gels were from Kodak.  
 
 
Bacterial strains and plasmids 
 
The host strain background for most of the plasmid constructions and in vivo 
assays was Escherichia coli K-12 strain MH13312 (mcrA Δpro-lac thi gyrA endA hsdR 
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relR supE44 recA / F' pro+ lacIQ1 ΔlacZY), a derivative of JM109 carrying an F’ plasmid 
deleted for both lacZ and lacY and expressing higher than normal levels of Lac repressor 
(Artsimovitch and Howe, 1996). It has no antibiotic resistance. Strain MH13435 was 
made by transforming plasmid pIA14, that has wild-type Pm sequence from -61 to +10 
fused to lacZ, into MH13312. Plasmid pIA14 has the ampicillin resistance gene. Strain 
MH13418 was made by transforming plasmid pIA69, which has the his-mor gene under 
the control of IPTG-inducible PlacUV5 promoter, into MH13312. This was used as a host 
for transformation for phenotypic and quantitative assays of the ability of Mor to activate 
transcription from the various mutations introduced into Pm. Plasmid pIA69 has the 
chloramphenicol resistance gene. Strain MH13315 with plasmid pIA12, which does not 
have a wild-type promoter, Pm was used as a vector for all clonings to facilitate selection 
of clones.  Plasmid pIA12 has the ampicillin resistance gene. Strain MH13355 is the 
protein expression strain, containing λDE3 that encodes T7 RNA polymerase used for 
protein over-expression and detection of wild-type protein His-Mor. 
 
 
Oligonucleotide synthesis 
 
Oligonucleotides were synthesized by Integrated DNA Technologies Inc. on a 
commercial nucleic acid synthesizer, Model ABI394, using the phosphoramidite 
chemistry method (Caruthers et al, 1983). For Mod-PCR mutagenesis (Chiang and Howe 
1993) degeneracy was introduced into the targeted position by simultaneous delivery of 
equal volumes of solution of wild-type nucleotide and an equimolar mix of all four 
nucleotides resulting in a mis-incorporation rate of 0.25/nucleotide. To get a higher 
frequency of specific nucleotide, especially T, degenerate oligo MUT 52 was ordered 
with a higher frequency of T in all four positions. For site specific mutagenesis, 
nucleotides indicated in the table were delivered at the specific positions. The sequence 
of oligonucleotides used for mutagenesis, sequencing and probe preparation in this 
chapter are shown in Table 3. All the oligonucleotides were diluted to a working 
concentration of 100 picomoles/ul. 
 
 
Targeted mutagenesis 
 
Mutagenesis of the spacer region was specifically targeted at the four bases of the 
spacer from -42 through -45 positions of Pm with respect to the transcription start site of 
+1 and the effect of these mutations were studied for the contribution of the minor groove 
bases in interaction with His-Mor. Three degenerate primers were designed to introduce 
all possible substitutions in the spacer:   
 
1. MUT 50: This top strand oligonucleotide was designed with NCCN in the spacer 
region with degeneracy at the first and the fourth positions. 
2. MUT 51: This top strand oligonucleotide was designed with GNNG in the spacer 
region with middle two positions of the spacer degenerate. 
3. MUT 52: This top strand oligonucleotide was designed with NNNN in the spacer 
region with degeneracy at all four positions. 
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Table 3: Oligonucleotides used for promoter mutagenesis. 
 
Primer 
 
Sequence Comments 
KRI 125 GGCGAATTCTTCTGTAAACAGTAAC
GCCGGTTAATC 
Top strand mutagenic primer 
designed to incorporate 
mutation 1 in Pm.  
KRI 126 GGCGAATTCTTCTGTAAAGAGTAAA
GCCGGTTAATC 
Top strand mutagenic primer 
designed to incorporate 
mutation 5 in Pm. 
KRI 127 GGCGAATTCTTCTGTAAGCAGTAAA
GCCGGTTAATC 
Top strand mutagenic primer 
designed to incorporate 
mutation 8 in Pm. 
KRI 128 GGCGAATTCTTCTGTACACAGTAAA
GCCGGTTAATC 
Top strand mutagenic primer 
designed to incorporate 
mutation 10 in Pm. 
KRI 129 GGCGAATTCTTCTTTAAACAGTAAA
GCCGGTTAATC 
Top strand mutagenic primer 
designed to incorporate 
mutation 14 in Pm. 
KRI 130 GGCGAATTCTTCTGTAAACATTAAC
GCCGGTTAATC 
Top strand mutagenic primer 
designed to incorporate 
mutation 17 in Pm. 
KRI 131 GGCGAATTCTTCTGTAAACAGTAAA
AAAAGTTAATC 
Top strand mutagenic primer 
designed to incorporate 
mutation 18 in Pm. 
KRI 132 GGCGAATTCTTCTGTAAACAGTAAA
TAATGTTAATC 
Top strand mutagenic primer 
designed to incorporate 
mutation 19 in Pm. 
KRI 133 GGCGAATTCTTCTGTAAACAGTAAA
CCGGGTTAATC 
Top strand mutagenic primer 
designed to incorporate 
mutation 20 in Pm. 
KRI 134 GGCGAATTCTTCTGTAAACAGTAAA
GGGGGTTAATC 
Top strand mutagenic primer 
designed to incorporate 
mutation 21 in Pm. 
KRI 135 GGCGAATTCTTCTTTAAGCAGTAAA
GCCGGTTAATC 
Top strand mutagenic primer 
designed to incorporate 
mutation 23 in Pm. 
KRI 136 GGCGAATTCTTCTGTAAACATTAAA
GCCGGTTAATC 
Top strand mutagenic primer 
designed to incorporate 
mutation 26 in Pm. 
KRI 137 GGCGAATTCTTCTGTAAACAGTAAA
GCCGGTTAATCCTGCTTTTTTTACG 
Top strand mutagenic primer 
designed to incorporate 
mutation 9 in Pm. 
KRI 138 GGCGAATTCTTCTGTAAACAGTAAA
GCCGGTTAATCCGTCTTTTTTTACG 
Top strand mutagenic primer 
designed to incorporate 
mutation 11 in Pm. 
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Table 3 (continued). 
 
Primer 
 
Sequence Comments 
KRI 139 GGCGAATTCTTCTGTAAACAGTAAA
GCCGGTTAATCCGGATTTTTTTACG 
Top strand mutagenic primer 
designed to incorporate 
mutation 12 in Pm. 
KRI 140 GGCGAATTCTTCTGAAAACAGTAAA
GCCGGTTAATCCGGTTTTTTTTACG 
Top strand mutagenic primer 
designed to incorporate 
mutation 13 in Pm. 
KRI 141 GGCGAATTCTTCTTTAAACAGTAAA
GCCGGTTAATCCGGCATTTTTTACG 
Top strand mutagenic primer 
designed to incorporate 
mutation 15 in Pm. 
KRI 142 GGCGAATTCTTCTGTAAACAGTAAA
GCCGTTTAATCCGGCTTTTTTTACG 
 
Top strand mutagenic primer 
designed to incorporate 
mutation 2 in Pm. 
KRI 143 GGCGAATTCTTCTGTAAACAGTCAA
GCCGGTGAATCCGGCTTTTTTTACG 
 
Top strand mutagenic primer 
designed to incorporate 
mutation 3 in Pm. 
KRI 144 GGCGAATTCTTCTGTAAACAGTAAA
GCCGGTTACTCCGGCTTTTTTTACG 
 
Top strand mutagenic primer 
designed to incorporate 
mutation 4 in Pm. 
KRI 145 GGCGAATTCTTCTGTAAAAAGTAAA
GCCGGTTAATTCGGCTTTTTTTACG 
 
Top strand mutagenic primer 
designed to incorporate 
mutation 6 in Pm. 
KRI 146 GGCGAATTCTTCTGTAAACAGTAAA
GCCGGTTAATCTGGCTTTTTTTACG 
 
Top strand mutagenic primer 
designed to incorporate 
mutation 7 in Pm. 
KRI 147 GGCGAATTCTTCTGTAAACATTAAA
GCCGTTTAATCCGGCTTTTTTTACG 
Top strand mutagenic primer 
designed to incorporate 
mutation 16 in Pm. 
KRI 148 GGCGAATTCTTCTTTAAGCAGTAAA
GCCGGTTAATCCGGTTTTTTTTACG 
Top strand mutagenic primer 
designed to incorporate 
mutation 22 in Pm. 
KRI 149 GGCGAATTCTTCTTTAAACAGTAAA
GCCGGTTAATCCGGTTTTTTTTACG 
Top strand mutagenic primer 
designed to incorporate 
mutation 24 in Pm. 
KRI 150 GGCGAATTCTTCTGTAAGCAGTAAA
GCCGGTTAATCCGGTTTTTTTTACG 
Top strand mutagenic primer 
designed to incorporate 
mutation 25 in Pm. 
KRI 151 GGCGAATTCTTCTGTAAACAGTTAA
GCCGGTAAATCCGGCTTTTTTTACG 
Top strand mutagenic primer 
designed to incorporate 
mutation 27 in Pm. 
KRI 152 GGCGAATTCTTCTGTAAACAGATTA
GCCGGAATATCCGGCTTTTTTTACG 
Top strand mutagenic primer 
designed to incorporate 
mutation 28 in Pm. 
 44
Table 3 (continued). 
 
Primer 
 
Sequence Comments 
KRI 153 GGCGAATTCTTCTGTAAACATATTCG
CCGGAATATCCGGCTTTTTTTACG 
Top strand mutagenic primer 
designed to incorporate 
mutation 29 in Pm. 
MUT 50 GGCGAATTCTTCTGTAAACAGTAAA
NCCNGTTAATC 
Top strand degenerate primer 
to mutagenize the last two 
positions of the spacer. 
MUT 51 GGCGAATTCTTCTGTAAACAGTAAA
GNNGGTTAATC 
Top strand degenerate primer 
to mutagenize the middle two 
positions of the spacer. 
MUT 52 GGCGAATTCTTCTGTAAACAGTAAA
NNNNGTTAATC 
Top strand degenerate primer 
to mutagenize all four 
positions of the spacer. 
MUT 528 GGCGAATTCTTCTGTAAACAGTAAA
GGACGTTAATC 
Top strand mutagenic primer 
with GGAC in the spacer 
region. 
MUT 529 GGCGAATTCTTCTGTAAACAGTAAA
GACGGTTAATC 
Top strand mutagenic primer 
with GAGC in the spacer 
region. 
MUT 530 GGCGAATTCTTCTGTAAACAGTAAA
ACCCGTTAATC 
Top strand mutagenic primer 
with ACCC in the spacer 
region. 
MLK 7 CCTGGATCCGTACGGTTATTCATCAC
AG 
Bottom strand wild-type 
primer to be used with all the 
above primers for PCR 
amplification. 
 
The oligonucleotide sequences are written from the 5’ to 3’direction. The letters in red 
indicate the mutations introduced. The numbers in bold red are the mutations as they 
were numbered in this study. 
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The rationale behind the various degenerate oligonucleotides was that if Q68 and 
Y70 contacted the bases of the minor grove spacer:  
 
1. If it made contacts with the G’s, then we would get more frequency of mutant 
phenotypes with MUT 50 and MUT 52.  
2. If it made contacts with the C’s then we would get more frequency of mutant 
phenotypes with MUT 51 and MUT 52. 
3. If all four positions were equally important for the contacts of the side chains of 
the amino acids then we would get more or less equal distribution of mutant 
phenotypes with all the three degenerate oligonucleotides. 
 
A single step PCR mutagenesis was carried out with degenerate top strand 
primers MUT 50, MUT 51 and MUT 52 and the bottom strand wild-type primer MLK 7 
in separate reactions. This introduced a library of substitutions in the spacer region 
corresponding to the various bases in the degenerate oligonucleotides. For introducing all 
other mutations in Pm, primers with the specific mutations were designed as given in the 
Table 3 and a single step PCR mutagenesis was carried out with these top strand primers 
and the bottom strand wild-type primer MLK 7 in separate reactions. Thus, the PCR 
products had incorporated the specific mutations that were designed for mutagenesis of 
the various positions of Pm. The program used for amplification was as follows: 1 min at 
94°C, 1 min at 50°C and 1 min at 72°C for 30 cycles followed by 5 min at 72°C in a 
PTC-100 thermal cycler (MJ Research Inc., Watertown, MA). All the mutagenic 
oligonucleotides had the EcoR1 site at its 5’ end preceded by 3 extra nucleotides and the 
primer MLK 7 had the BamH1 site followed by additional nucleotides to facilitate 
restriction digest of the insert PCR products.  
 
  The rest of the experimental protocol was similar for both the spacer region 
mutagenesis and all other Pm mutations. PCR products were cleaned up using Qiaquick 
PCR purification kit and then subjected to double restriction digest with EcoR1 and 
BamH1 at 37°C for 4 hours. The vector pIA14 that was used for spacer region 
mutagenesis and vector pIA12 that was used for all other Pm mutagenesis were also 
subjected to similar restriction digests and also phosphatased with shrimp alkaline 
phosphatase to prevent re-ligation of vectors cut by just one enzyme. Ligation reactions 
with the digested PCR products as inserts and digested vector were incubated at 16°C 
overnight for about 18-20 hours. The ligation mixture was transformed into MH13418 
competent cells, which has His-Mor containing pIA69 plasmid. 
 
 
Determination of plate phenotypes 
 
Transformants were plated on MacConkey lactose agar plates with 
chloramphenicol (25 μg/ml), ampicillin (40 μg/ml) and IPTG (50 μM). The two plasmid 
system was used throughout this study. The promoter plasmid, pIA14 has ampicillin 
resistance and the protein plasmid, pIA69 has chloramphenicol resistance. The bacterial 
cells which have both the plasmids will grow on plates with ampicillin and 
chloramphenicol. The induction of His-Mor expression is through the action of IPTG 
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which induces the PlacUV5 promoter in pIA69 plasmid. The His-Mor thus expressed, binds 
to Pm on the pIA12 derivative, pIA14 which had the wild-type Pm or the cloned Pm with 
mutations. Gene lacZ is immediately downstream of the Pm promoter and is under its 
control for activity. Figure 14 illustrates the two plasmid system.  
 
The level of activation of Pm depends on the interaction of His-Mor with the 
promoter and this determines the level of expression of the lacZ gene. Normal expression 
of lacZ is indicated by a red color on MacConkey plates and any defect in its expression 
is observed by a different colony phenotype. Red colonies with a white halo indicate 
lower than wild-type expression of lacZ. No expression of lacZ is observed as white 
colonies on the plate. Red centered phenotype indicates an intermediate expression. The 
expression levels of lacZ from the plate phenotyping and in vivo β-galactosidase activity 
can thus be used to study interactions between His-Mor, promoter DNA and RNAP. 
 
The phenotypic frequency of the mutant libraries was calculated based on the 
distribution of different phenotypes among the candidates. Plate phenotyping was done 
by observing the color of the colonies on the MacConkey lactose agar plates after 
incubating the plates at 37°C for 16 hours. The fully functional mutations of Pm gave red 
colonies similar to wild-type and the defective ones gave red centered or white 
phenotypes depending on partially defective or fully defective phenotypes. The colors 
were scored relative to those of positive control (wild-type pIA14 plasmid in 
transformation) and the negative control (transformation of pIA12 which lacks Pm). A 
few candidates from each phenotype were selected and purified and their promoter 
plasmids, pIA14 were sequenced to identify the mutations. 
 
 
Preparation of competent cells 
 
Competent cells were prepared by CaCl2 method (Mandel and Higa, 1970): 
  
1. MH13418, which has the protein His-Mor plasmid pIA69, was streaked on LB 
agar plate with chloramphenicol (25 μg/ml) and was incubated overnight at 37˚C. 
2. Single colony was inoculated into 5 ml plain LB and grown overnight at 37˚C 
shaker. 
3. Next morning, the seed culture was inoculated into 100 ml plain LB w/o 
antibiotics and grown in 37˚C shaker till the OD reached 0.4-0.6 (for about 3 hrs). 
4. Flasks were kept on ice for 15 min. 
5. 25 ml of the culture was taken in each of the 30 ml Corex tubes and centrifuged at 
10000 rpm for 15 min (SS34 rotor) and the supernatant was discarded. 
6. 12.5 ml (50% of culture volume) sterile 0.1 M CaCl2 was taken in each tube and 
left for 15 min. on ice and then resuspended. 
7. It was centrifuged at 10000 rpm for 15 min (SS34 rotor) and the supernatant was 
discarded. The pellet was resuspended in 2.5 ml CaCl2 and 375 µl glycerol. 
8. Resuspended cells were left in cold room for 2 hrs to overnight, distributed into 
200 μl aliquots, flash-frozen and stored at -80˚C freezer. 
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Figure 14: The two plasmid system used to study interactions of Pm with His-Mor. 
 
Modified with permission from Nucleic Acids Research. Artsimovitch I, Howe M. 
Transcription activation by the bacteriophage Mu Mor protein: analysis of promoter 
mutations in Pm identifies a new region required for promoter function. Nucl. Acids Res. 
1996, 24(3): 450-7. 
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Transformation protocol 
 
The MH13418 competent cells were thawed on ice for 30 min. The ligation mix 
was then added into the competent cells tube and left standing for 30 min on ice. Heat 
shock treatment was given for exactly 2 min at 42˚C and then the tubes were placed 
immediately on ice for 10 min. The entire volume of cells was grown on 2 ml LB broth 
for 2 hrs on 37˚C shaker. 150 µl of the outgrowth transformants was plated on 
MacConkey lactose agar plates with chloramphenicol (25 μg/ml), ampicillin (40 μg/ml) 
and IPTG (50 μM) for plate phenotyping and selection of the clones. 
 
 
Plasmid purification protocol 
 
Wizard Plus Midiprep DNA Purification kit from Promega Corporation was used 
for the extraction of the plasmids pIA14 from MH13435 and pIA12 from MH13315.  
 
1. The strain was streaked on LB agar plates with ampicillin (40 μg/ml) and left 
overnight in 37˚C incubator. 
2. A single colony was inoculated into 100 ml LB broth with ampicillin (40 μg/ml) 
and grown overnight in 37˚C shaker. 
3. Cells were pelleted at 8000 rpm for 18 min at 4˚C. 
4. The pellet was resuspended in 3 ml cell resuspension solution provided in the kit. 
5. The cells were lysed in 3ml cell lysis solution provided in the kit. 
6. The reaction was neutralized using 3 ml neutralization Solution from the kit. 
7. It was then centrifuged at 12000 rpm for 15 min at 4˚C. 
8. The supernatant was mixed with the resuspended resin and allowed to pass 
through the midiprep column from the kit in a vacuum manifold. 
9. After all the liquid passed through the column, it was washed twice with 15 ml 
column wash solution. 
10. The plasmid from the column was extracted with 300 µl preheated milliQ water 
by centrifugation for 20 sec at 10000 rpm. 
 
The plasmid preparation thus obtained was further purified with ethaonol 
precipitation for further purity as follows: 
  
1. 30 µl sodium acetate and 750 µl absolute ethanol was added to the 300 µl plasmid 
preparation and kept standing at -80˚C for about 40 min. 
2. The DNA was centrifuged at 10000 rpm for 10 min and the supernatant was 
discarded. 
3. The DNA pellet was washed twice in 1ml of 70% ethanol.  
4. The pellet was then dried in vacuum for 10 min and then resuspended in 150 µl 
milliQ water at pH 8.0. 
 
The purified DNA was observed on a 1% agarose gel and quantitated on the 
Thermo Scientific NanoDropTM 1000 Spectrophotometer.  
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Sequencing of the plasmids 
 
All the plasmids were sequenced using MUT 49 as the bottom strand sequencing 
primer at the Molecular Resource Center (MRC) facility at the University of Tennessee 
Health Science Center, Memphis. At the MRC, automated DNA sequencing was 
accomplished with ABI Model 3130XL Genetic Analyzers that use four-color 
fluorescence-based sequencing based on the Sanger method. Plasmid or PCR produced 
DNAs were used as suitable substrates for the sequencing protocol. Samples were 
submitted as template/primer mixes, with the ratio of DNA/primer dependent on the type 
of template employed. Following the incorporation of the labeled ddNTPs in the 
extension products, the reactions were purified by gel filtration, dried down, re-suspended 
in formamide, and run on the analyzer. DNA sequencing reactions were purified with the 
BigDye® XTerminator™ Purification Kit result in high signal strength when analyzed on a 
DNA sequencer. Data were uploaded on the MRC server as either ab.1 files that could be 
opened with ABI software or programs such as FinchTv or text files. Electropherograms, 
which are the graphic colored printouts of the sequencing, were used to read the 
sequences. A BLAST was performed for each of the sequences with “bl2seq” from the 
NCBI site, using the sequence from wild-type promoter and the two sequences were 
aligned and the base-pair mismatches were observed to check the incorporation of the 
specific mutations designed. 
 
 
Small scale purification of His-Mor 
 
Overnight cultures (2 ml) of MH13355 protein expression strain with freshly 
transformed His-Mor plasmid were transferred to 100 ml of LB supplemented with 25 
μg/ml of chloramphenicol. The cells were grown at 37˚C until the A600 reached 0.4 - 0.6, 
and then His-Mor over-expression was induced with 1 mM IPTG for 3 hrs. After 
harvesting by centrifugation at 8000 rpm for 15 min at 4˚C, the cell pellets were 
resuspended in 4 ml of Resuspension Buffer M containing 20 mM Tris-HCl pH 7.9, 200 
mM NaCl, 0.5 mM phenylmethylsulfonylfluoride, 10% glycerol, 1 mM 2-
mercaptoethanol and lysed by sonication (output 40 cycles 4 for 4 minutes). After 
centrifugation, the supernatants were loaded into TALON spin columns (now 
equilibrated thrice with Buffer M) and washed sequentially once with 1 ml of BufferM 
containing 0.1% IGEPAL CA-630 detergent, once with 1 ml of Buffer M containing 500 
mM NaCl and once with 1 ml of Buffer M containing 40 mM imidazole. Proteins were 
eluted four times, 0.25 ml/time, with Buffer M containing 100 mM imidazole. The final 
two elutions were pooled together. The second elution and the pooled fractions were 
dialysed overnight at 4˚C in a 10-kDa cutoff Slide-A-lyzer dialysis cassette in the dialysis 
buffer solution (20 mM Tris-HCl pH 7.9, 50 mM NaCl, 10% glycerol, 1 mM EDTA, and 
1 mM DTT). It was then supplemented with glycerol to a final concentration of 15%, 
aliquoted and stored at -80˚C. Purity of the preparations was assayed on a 12.5% SDS 
polyacrylamide gel stained with silver nitrate, and the protein concentration was 
determined by a Bradford assay with IgG as the standard (Bradford, 1976). 
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In vivo transactivation assay 
 
  Cells were grown overnight in 2 ml of M9CA medium [M9 media (20% 5X M9 
salts, 20 mM glucose, 2 mM MgSO4, 0.1 mM CaCl2, 10 μg/ml each of thiamine and 
Biotin) + 0.2% casamino acid] supplemented with 25-30 μg/ml chloramphenicol and 40 
μg/ml ampicillin. The overnight culture was diluted 1:50 into 10 ml of fresh M9CA 
medium with antibiotics and grown at 37˚C until the A600 reached 0.4 - 0.6. A 1-ml 
sample was removed to serve as an uninduced control, and the remaining culture was 
induced with 2 mM IPTG for 60 min. Based on the plate phenotype of individual 
mutants, dilutions of the cells were made using M9CA medium, and the cells were 
permeabilized by mixing with 10 μl of chloroform and 25 μl of 0.1% SDS.  After 
incubation for 20 min on ice, 0.5 ml of ONPG (4 mg/ml to a final concentration of 0.8 
μg/μl) in Buffer Z (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4 and 
50 mM 2-mercaptoethanol) was added, and the mixture was incubated at 28˚C for 20 
min. The reactions were stopped by adding 250 μl of 1 M Na2CO3 and spectrophotometer 
readings were taken at 420 nm for the enzymatic reaction and 600 nm for cell density. 
The β-galactosidase activities were calculated according to Miller’s formula (Miller, 
1972) and normalized relative to that of a wild-type culture assayed in parallel and set to 
1000. 
 
 
Gel mobility shift assay 
 
The list of oligonucleotides used for gel shifts is given in Table 4. All the bottom 
strand oligonucleotides were radioactively labeled. Labeled probes were prepared using 
γ-P32 labeled bottom strand primer in a 10 μl labeling reaction with 1 μl T4 
polynucleotide kinase, 4 μl milliQ water, 1 μl kinase buffer and 3 μl γ-P32 ATP (500 
μCurie stock from Perkin Elmer) and incubated at 37˚C for 60 min and then at 95˚C for 2 
min to inactivate the enzyme. Then, 1.1 μl of 0.5 M NaCl (final concentration of 50 mM), 
and 5 μl of the top strand oligo was added to the reaction mix, kept on a 100˚C heat block 
and the block was disconnected for the oligonucleotides to anneal gradually as the 
temperature drops from 100˚C to room temperature. After it drops to room temperature, 
35 μl binding buffer (20 mM Tris-HCl pH 7.9, 50 mM NaCl, 5% glycerol and 1 mM 
DTT) was added and the double stranded radioactively labeled oligonucleotides were 
purified using G25 (for oligonucleotides from 10-20 bases in length) and G50 (for 
oligonucleotides 20-50 bases in length) columns from GE Healthcare. 
 
A 20 μl reaction volume containing probe (about 30 radioactive counts per second 
as measured with a Geiger counter), 50 ng of calf-thymus DNA, and different 
concentrations of His-Mor protein in binding buffer (20 mM Tris-HCl pH 7.9, 50 mM 
NaCl, 5% glycerol and 1 mM DTT) was incubated at room temperature for 20 minutes. 
Two different amounts (400 ng and 800 ng) of wild-type His-Mor were used with each of 
the labeled probes in most cases while in some cases three amounts (200 ng, 400 ng and 
800 ng) of protein was used. There was one tube with a negative control without His-Mor 
and with the probe alone. One positive control was used for every gel which had the 
wild-type promoter Pm labeled probe with wild-type His-Mor. 
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Table 4: List of oligonucleotides for gel shifts. 
 
Oligo 
numbers 
Sequence Comments 
KRI 57 CAGTAAAGCCGGTTAATC Top strand 18-mer 
oligo probe. 
KRI 58 GATTAACCGGCTTTACTG Bottom strand 18-mer 
oligo probe. 
KRI 59 ACAGTAAAGCCGGTTAATCC Top strand 20-mer 
oligo probe. 
KRI 60 GGATTAACCGGCTTTACTGT Bottom strand 20-mer 
oligo probe. 
MUT 18 AACAGTAAAGCCGGTTAATCCG Top strand 22-mer 
oligo probe. 
MUT 19 CGGATTAACCGGCTTTACTGTT Bottom strand 22-mer 
oligo probe 
KRI 49 AAACAGTAAAGCCGGTTAATCCGG Top strand 24-mer 
oligo probe. 
KRI 50 CCGGATTAACCGGCTTTACTGTTT Bottom strand 24-mer 
oligo probe. 
KRI 51 TAAACAGTAAAGCCGGTTAATCCGGC Top strand 26-mer 
oligo probe. 
KRI 52 GCCGGATTAACCGGCTTTACTGTTTA Bottom strand 26-mer 
oligo probe. 
KRI 53 GTAAACAGTAAAGCCGGTTAATCCGGCT Top strand 28-mer 
oligo probe. 
KRI 54 AGCCGGATTAACCGGCTTTACTGTTTAC Bottom strand 28-mer 
oligo probe. 
KRI 55 TGTAAACAGTAAAGCCGGTTAATCCGGCTT Top strand 30-mer 
oligo probe. 
KRI 56 AAGCCGGATTAACCGGCTTTACTGTTTACA Bottom strand 30-mer 
oligo probe. 
KRI 61 TGTAAACAGTAACGCCGGTTAATCCGGCTT Top strand 30-mer 
oligo probe with 
mutation 1 in Pm. 
KRI 62 AAGCCGGATTAACCGGCGTTACTGTTTACA Bottom strand 30-mer 
oligo probe with 
mutation 1 in Pm. 
KRI 63 TGTAAACAGTAAAGCCGTTTAATCCGGCTT Top strand 30-mer 
oligo probe with 
mutation 2 in Pm. 
KRI 64 AAGCCGGATTAAACGGCTTTACTGTTTACA Bottom strand 30-mer 
oligo probe 
containing mutation 2 
in Pm. 
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Table 4 (continued). 
 
Oligo 
numbers 
Sequence Comments 
KRI 65 TGTAAACAGTCAAGCCGGTGAATCCGGCTT Top strand 30-mer 
oligo probe with 
mutation 3 in Pm. 
KRI 66 AAGCCGGATTCACCGGCTTGACTGTTTACA Bottom strand 30-
mer oligo probe with 
mutation 3 in Pm. 
KRI 67 TGTAAACAGTAAAGCCGGTTACTCCGGCTT Top strand 30-mer 
oligo probe with 
mutation 4 in Pm. 
KRI 68 AAGCCGGAGTAACCGGCTTTACTGTTTACA Bottom strand 30-
mer oligo probe with 
mutation 4 in Pm. 
KRI 69 TGTAAAGAGTAAAGCCGGTTAATCCGGCTT Top strand 30-mer 
oligo probe with 
mutation 5 in Pm. 
KRI 70 AAGCCGGATTAACCGGCTTTACTCTTTACA Bottom strand 30-
mer oligo probe with 
mutation 5 in Pm. 
KRI 71 TGTAAAAAGTAAAGCCGGTTAATTCGGCTT Top strand 30-mer 
oligo probe with 
mutation 6 in Pm. 
KRI 72 AAGCCGAATTAACCGGCTTTACTTTTTACA Bottom strand 30-
mer oligo probe with 
mutation 6 in Pm. 
KRI 73 TGTAAACAGTAAAGCCGGTTAATCTGGCTT Top strand 30-mer 
oligo probe with 
mutation 7 in Pm. 
KRI 74 AAGCCAGATTAACCGGCTTTACTGTTTACA Bottom strand 30-
mer oligo probe with 
mutation 7 in Pm. 
KRI 75 TGTAAGCAGTAAAGCCGGTTAATCCGGCTT Top strand 30-mer 
oligo probe with 
mutation 8 in Pm. 
KRI 76 AAGCCGGATTAACCGGCTTTACTGCTTACA Bottom strand 30-
mer oligo probe with 
mutation 8 in Pm. 
KRI 77 TGTAAACAGTAAAGCCGGTTAATCCTGCTT Top strand 30-mer 
oligo probe with 
mutation 9 in Pm. 
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Table 4 (continued). 
 
Oligo 
numbers 
Sequence Comments 
KRI 78 AAGCAGGATTAACCGGCTTTACTGTTTACA Bottom strand 30-
mer oligo probe with 
mutation 9 in Pm. 
KRI 79  TGTACACAGTAAAGCCGGTTAATCCGGCTT Top strand 30-mer 
oligo probe with 
mutation 10 in Pm. 
KRI 80 AAGCCGGATTAACCGGCTTTACTGTGTACA Bottom strand 30-
mer oligo probe with 
mutation 10 in Pm. 
KRI 81 TGTAAACAGTAAAGCCGGTTAATCCGTCTT Top strand 30-mer 
oligo probe with 
mutation 11 in Pm. 
KRI 82 AAGACGGATTAACCGGCTTTACTGTTTACA Bottom strand 30-
mer oligo probe with 
mutation 11 in Pm. 
KRI 83 TGTAAACAGTAAAGCCGGTTAATCCGGATT Top strand 30-mer 
oligo probe with 
mutation 12 in Pm. 
KRI 84 AATCCGGATTAACCGGCTTTACTGTTTACA Bottom strand 30-
mer oligo probe with 
mutation 12 in Pm. 
KRI 85 TGAAAACAGTAAAGCCGGTTAATCCGGTTT Top strand 30-mer 
oligo probe with 
mutation 13 in Pm. 
KRI 86 AAACCGGATTAACCGGCTTTACTGTTTTCA Bottom strand 30-
mer oligo probe with 
mutation 13 in Pm. 
KRI 87 TTTAAACAGTAAAGCCGGTTAATCCGGCTT Top strand 30-mer 
oligo probe with 
mutation 14 in Pm. 
KRI 88 AAGCCGGATTAACCGGCTTTACTGTTTAAA Bottom strand 30-
mer oligo probe with 
mutation 14 in Pm. 
KRI 89  TTTAAACAGTAAAGCCGGTTAATCCGGCAT Top strand 30-mer 
oligo probe with 
mutation 15 in Pm. 
KRI 90 ATGCCGGATTAACCGGCTTTACTGTTTAAA Bottom strand 30-
mer oligo probe with 
mutation 15 in Pm. 
KRI 91 TGTAAACATTAAAGCCGTTTAATCCGGCTT Top strand 30-mer 
oligo probe with 
mutation 16 in Pm. 
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Table 4 (continued). 
 
Oligo 
numbers 
Sequence Comments 
KRI 92 AAGCCGGATTAAACGGCTTTAATGTTTACA Bottom strand 30-
mer oligo probe with 
mutation 16 in Pm. 
KRI 93 TGTAAACATTAACGCCGGTTAATCCGGCTT Top strand 30-mer 
oligo probe with 
mutation 17 in Pm. 
KRI 94 AAGCCGGATTAACCGGCGTTAATGTTTACA Bottom strand 30-
mer oligo probe with 
mutation 17 in Pm. 
KRI 95 TGTAAACAGTAAAAAAAGTTAATCCGGCTT Top strand 30-mer 
oligo probe with 
mutation 18 in Pm. 
KRI 96 AAGCCGGATTAACTTTTTTTACTGTTTACA Bottom strand 30-
mer oligo probe with 
mutation 18 in Pm. 
KRI 97 TGTAAACAGTAAATAATGTTAATCCGGCTT Top strand 30-mer 
oligo probe with 
mutation 19 in Pm. 
KRI 98 AAGCCGGATTAACATTATTTACTGTTTACA Bottom strand 30-
mer oligo probe with 
mutation 19 in Pm. 
KRI 99 TGTAAACAGTAAACCGGGTTAATCCGGCTT Top strand 30-mer 
oligo probe with 
mutation 20 in Pm. 
KRI 100 AAGCCGGATTAACCCGGTTTACTGTTTACA Bottom strand 30-
mer oligo probe with 
mutation 20 in Pm. 
KRI 101 TGTAAACAGTAAAGGGGGTTAATCCGGCTT Top strand 30-mer 
oligo probe with 
mutation 21 in Pm. 
KRI 102 AAGCCGGATTAACCCCCTTTACTGTTTACA Bottom strand 30-
mer oligo probe with 
mutation 21 in Pm. 
KRI 103 TTTAAGCAGTAAAGCCGGTTAATCCGGTTT Top strand 30-mer 
oligo probe with 
mutation 22 in Pm. 
KRI 104 AAACCGGATTAACCGGCTTTACTGCTTAAA Bottom strand 30-
mer oligo probe with 
mutation 22 in Pm. 
KRI 105 TTTAAGCAGTAAAGCCGGTTAATCCGGCTT Top strand 30-mer 
oligo probe with 
mutation 23 in Pm. 
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Table 4 (continued). 
 
Oligo 
numbers 
Sequence Comments 
KRI 106 AAGCCGGATTAACCGGCTTTACTGCTTAAA Bottom strand 30-
mer oligo probe with 
mutation 23 in Pm. 
KRI 107 TTTAAACAGTAAAGCCGGTTAATCCGGTTT Top strand 30-mer 
oligo probe with 
mutation 24 in Pm. 
KRI 108 AAACCGGATTAACCGGCTTTACTGTTTAAA Bottom strand 30-
mer oligo probe with 
mutation 24 in Pm. 
KRI 109 TGTAAGCAGTAAAGCCGGTTAATCCGGTTT Top strand 30-mer 
oligo probe with 
mutation 25 in Pm. 
KRI 110 AAACCGGATTAACCGGCTTTACTGCTTACA Bottom strand 30-
mer oligo probe with 
mutation 25 in Pm. 
KRI 111 TGTAAACATTAAAGCCGGTTAATCCGGCTT Top strand 30-mer 
oligo probe with 
mutation 26 in Pm. 
KRI 112 AAGCCGGATTAACCGGCTTTAATGTTTACA Bottom strand 30-
mer oligo probe with 
mutation 26 in Pm. 
KRI 113 TGTAAACAGTTAAGCCGGTAAATCCGGCTT Top strand 30-mer 
oligo probe with 
mutation 27 in Pm. 
KRI 114 AAGCCGGATTTACCGGCTTAACTGTTTACA Bottom strand 30-
mer oligo probe with 
mutation 27 in Pm. 
KRI 115 TGTAAACAGATTAGCCGGAATATCCGGCTT Top strand 30-mer 
oligo probe with 
mutation 28 in Pm. 
KRI 116 AAGCCGGATATTCCGGCTAATCTGTTTACA Bottom strand 30-
mer oligo probe with 
mutation 28 in Pm. 
KRI 117 TGTAAACATATTCGCCGGAATATCCGGCTT Top strand 30-mer 
oligo probe with 
mutation 29 in Pm. 
KRI 118 AAGCCGGATATTCCGGCGAATATGTTTACA Bottom strand 30-
mer oligo probe with 
mutation 29 in Pm. 
KRI 119 ATTAACGCCGGTTAAT Top strand 16-mer 
oligo with mutation 
17 in Pm. 
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Table 4 (continued). 
 
Oligo 
numbers 
Sequence Comments 
KRI 120 ATTAACCGGCGTTAAT Bottom strand 16-
mer oligo with 
mutation 17 in Pm. 
KRI 121 CATTAACGCCGGTTAATC Top strand 18-mer 
oligo with mutation 
17 in Pm. 
KRI 122 GATTAACCGGCGTTAATG Bottom strand 18-
mer oligo with 
mutation 17 in Pm. 
KRI 123 ACATTAACGCCGGTTAATCC Top strand 20-mer 
oligo with mutation 
17 in Pm. 
KRI 124 GGATTAACCGGCGTTAATGT Bottom strand 20-
mer oligo with 
mutation 17 in Pm. 
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The reaction mixture subjected to electrophoresis on a 10% non-denaturing, 
native acrylamide gel  (19.5 ml milliQ water, 3 ml of 5X TBE buffer, 7.5 ml of 40% 29:1 
acrylamide/bis-acrylamide solution, 150 μl of 10% ammonium persulfate and 30 μl 
TEMED solution) and run in 0.5 X TBE buffer at 260 V for 90min at 4°C. Initial 
exposure of the gels to X-OMAT BioMax-MR film was done without drying for 6-18 
hours as indicated at -80˚C. The exposed films were then developed and observed for 
His-Mor binding to the labeled probes. Quantitative assays for the His-Mor binding was 
done in a phosphoimager using the Image Quant software which gave the percentage of 
the probe bound by wild-type His-Mor for each of the probes. 
 
 
Results 
 
 
Spacer region mutagenesis and phenotypic frequency 
 
For the spacer region, degenerate oligonucleotides were used to introduce all 
possible substitutions in the positions -42 through -45. The 3 primers that were designed 
for the purpose were: 
 
1. MUT 50 with NCCN in the spacer region with degeneracy at the first and the 
fourth positions. 
2. MUT 51 with GNNG in the spacer region with degeneracy at the middle two 
positions. 
3. MUT 52 with NNNN in the spacer region with degeneracy at all four positions. 
 
The initial analysis showed a very low incorporation of T in the oligonucleotides, 
so we ordered another primer MUT 520 with NNNN in the spacer region with a higher 
percentage of incorporation of T in all the four positions. The degenerate primers were 
designed for Mod-PCR (Chiang and Howe, 1993) in a way to change the targeted region 
by mutating the targeted bases to a random nucleotide using a 0.25 incorporation rate for 
each base A/T/G/C so that we got a library of substitutions in the region. 
  
The mutagenesis was performed in PCR reactions using one degenerate primer as 
the top strand primer and a wild-type primer, MLK 7 as the bottom strand primer. All the 
mutagenic oligonucleotides were designed in such a way that they had the EcoRI site at 
its 5’ end preceded by 3 extra nucleotides and the primer MLK 7 was designed with the 
BamHI site at its 5’ end followed by additional nucleotides to facilitate restriction digest. 
The resulting PCR products were digested with EcoRI and BamHI and cloned into a 
similarly digested vector, pIA14 such that the Pm region of pIA14 was removed and 
replaced with this library of mutations. The ligation mixture was transformed into 
MH13418 containing the plasmid pIA69 with the wild-type His-Mor gene inducible by 
IPTG. The vector itself is the reported plasmid with the Pm-lacZ fusion. The activities of 
mutant promoters were examined by the color development of the transformants on 
MacConkey lactose plates with chloramphenicol (25 μg/ml), ampicillin (40 μg/ml) and 
IPTG (50 μM).  
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The frequency of phenotypes in a mutant library was used as a preliminary 
indicator of the functional relevance of the bases in the spacer region. Mutant library with 
MUT 50 gave 13.2% white colonies indicating defective phenotypes. Mutant library with 
MUT 51 gave 11.2% white colonies, while the library with MUT 52 gave 9.8% whites. 
This initial analysis of the percentage of defective phenotypes was used as an indication 
as to the importance of the bases of the minor groove. Since just about 10% of colonies 
gave mutant phenotypes, it could be concluded that the minor groove spacer region can 
tolerate mutations and that interactions in the minor groove may not be base-specific. An 
equal proportion of red and white colonies were chosen for sequencing of the plasmids to 
determine the mutations incorporated in those positions.  
 
The 62 unique red sequences that were isolated are given in the Table 5 along 
with their corresponding β-gal values. Three unique sequences (GGAC, GACG and 
ACCC) were identified which conferred defective phenotypes. All other sequences which 
gave us defective phenotypes had mutations elsewhere in the plasmid, so they were not 
used for further analysis. To re-check the three mutations which gave defective 
phenotypes, these specific primers mutations were introduced in the spacer region. This 
time, majority of the clones had the wild-type phenotype even though they contained the 
specific mutations that previously gave defective phenotypes. This could be attributed to 
mutations elsewhere in the plasmid which gave defective phenotypes in the original 
cloning.  
 
 
Extensive mutagenesis of Pm 
 
In order to optimize Mor binding at Pm, extensive targeted mutagenesis was 
performed for the positions of Pm from -30 through -57 and specific mutations were 
introduced into those positions as given in Table 1. In addition to this, four specific 
mutations were also introduced in the 4-bp spacer region that was used as a subset of the 
spacer region mutants for analysis of in vivo transcription activation assays and gel shifts. 
Primers KRI 125 through KRI 153 were used for this purpose. The mutagenesis was 
performed in PCR reactions using one mutagenised primer as the top strand primer and a 
wild-type primer, MLK 7 as the bottom strand primer. All the mutagenic oligonucleotides 
were designed in such a way that they had an EcoRI site at its 5’ end preceded by 3 extra 
nucleotides and the primer MLK 7 was designed with the BamHI site at its 5’ end, again 
followed by additional nucleotides to facilitate restriction digestion of the PCR products 
with the two oligonucleotides. The resulting PCR products were digested with EcoRI and 
BamHI and cloned into a similarly digested vector, pIA12 such that the Pm region had 
incorporated the mutations designed for the specific positions. The ligation mixture was 
transformed into MH13418 containing the plasmid pIA69 with the wild-type his-mor 
gene inducible by IPTG. The vector itself is the reporter plasmid with the Pm-lacZ fusion. 
The activities of mutant promoters were examined by color development of the 
transformants on MacConkey lactose plates containing half the amount of lactose and 
also chloramphenicol (25 μg/ml), ampicillin (40 μg/ml) and IPTG (50 μM). 
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Table 5: Mutations of the spacer region which gave red colonies. 
 
-45 
G 
-44 
C 
-43 
C 
-42 
G 
β-GAL 
VALUES 
G C C A 784 
A C C A 1310 
A C C G 1189 
G C C C 1251 
G G G G 1058 
G A C G 689 
G A A G 946 
G G C G 1014 
G G A G 1360 
G A G G 729 
C A A A 1122 
T C G G 290 
A G C G 993 
A A A G 445 
G A G A 588 
G G C C 708 
C G A G 1222 
G C A G 637 
A C G G 1227 
C A A C 640 
C G G C 1223 
G G G A 964 
G A G C 772 
C A G G 945 
C C G C 574 
C C G G 485 
G A T G 547 
C C C A 516 
A A G G 713 
G T A G 850 
G C G A 439 
A G A A 864 
A A T G 1304 
G T A T 352 
T T T G 833 
T T A A 392 
A G C T 1264 
G T T T 888 
T T T T 410 
C C T A 664 
T G T T 574 
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Table 5 (continued). 
 
-45 
G 
-44 
C 
-43 
C 
-42 
G 
β-GAL 
VALUES 
A T T T 293 
C T T A 1149 
T A G T 480 
A T T A 902 
T T C G 927 
A A T T 729 
G T T G 745 
C G T C 849 
C C C T 934 
G C T T 551 
C A T T 433 
T G G T 580 
G C C C 1022 
T G C G 913 
G A C T 1077 
C T T T 549 
A C T C 756 
A C C C 917 
C T C T 728 
T C A G 323 
A A G A 549 
A A A A 579 
 
 
The positions of the bases are given at the top of each column with respect to the 
transcription start site of +1. Immediately following that, in the first row in red are the 
wild-type bases at each of those positions. The β-gal values are the readings from one 
experimental assay and are given with respect to the wild-type set to 1000 and the 
negative control calculated to be 2. 
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Observation of phenotypes 
 
The phenotypes of the transformants were observed after incubation of the plates 
at 37°C for 16 hours. The colonies were scored relative to the wild-type strain MH20655 
(positive control) which was red in color and the strain MH20656 (negative control) 
which had the vector plasmid pIA12, without Pm and was white on the MacConkey 
plates. The phenotypes were as given in Table 6. There were red colonies, reds with a 
white halo around them and white colonies as a result of the different mutations. The red 
colonies indicated those with wild-type promoter activity. The red ones with a small 
white halo indicated a slightly reduced activity as compared with wild-type and colonies 
which were red with a large white halo indicated an even more reduced activity. White 
colonies indicated a defective phenotype similar to the negative control with almost no 
detectable promoter activity.  
 
 
In vivo transactivation assay 
 
After one hour of Mor expression from the PlacUV5 promoter, the ability of Mor to 
activate transcription from Pm with the different mutations was assayed by measuring β-
galactosidase activity. They were done in parallel with a wild-type control. They are 
discussed with the results of the gel shifts as the effect of each mutation is discussed. The 
β-gal values are an average of two assays and are relative to the wild-type activity from 
wild-type Pm set to 1000. 
 
 
Gel retardation assay results 
 
Gel retardation assays were performed to test the ability of His-Mor to bind to the 
promoters with specific mutations. They were done at two concentrations of wild-type 
His-mor, 200 ng and 400 ng to determine the shift caused by the lowest concentration of 
the protein. Each gel had a control with 30-mer oligonucleotide which had the wild-type 
promoter and the intensity of the shift by the mutagenised oligonucleotides was scored 
relative to the control set to 100. The effects of gel shifts due to the mutations are 
discussed as a percentage of the wild-type in most cases except in cases where there was 
no detectable shift to assign a percent value to it. The results of the gel shift in correlation 
with the plate phenotypes and in vivo β-galactosidase activity levels are discussed on the 
following pages from Figure 15 through Figure 26. They are arranged as per the sequence 
of the mutations and the gels. 
 
 Both the in vivo transactivation assay values and gel retardation assay results are 
discussed with each mutation and also in the summarized results and discussion section. 
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Table 6: Phenotypes of strains with specific promoter mutations. 
 
Mutation 
 
Mutation alterations Strain 
 
Colony phenotype 
1 -46 A to C MH20561 Red with small white 
halo 
2 -41 G to T MH20616 Red with small white 
halo 
3 -48 A to C and 
-39 T to G 
MH20620 White 
4 
 
-37 A to C MH20624 Red 
5 -52 C to G MH20564 Red with small white 
halo 
6 -52 C to A and 
-35 C to T 
MH20627 Red 
7 -34 C to T 
 
MH20630 Red 
8 -53 A to G MH20567 Red with small white 
halo 
9 -33 G to T 
 
MH20600 Red 
10 -54 A to C MH20570 Red with larger white 
halo than others 
11 -32 G to T 
 
MH20603 Red 
12 -31 C to A 
 
MH20607 Red 
13 -56 T to A and 
-31 C to T 
MH20610 Red 
14 -57 G to T MH20575 Red with small white 
halo 
15 -57 G to T and 
-30 T to A 
MH 20614 Red with small white 
halo 
16 -50 G to T and 
-41 G to T 
MH20631 Red with small white 
halo 
17 -50 G to T and 
-46 A to C 
MH20576 Red with small white 
halo 
18 -42 through -45 
AAAA 
MH20584 Red with small white 
halo 
19 -42 through -45 
TAAT 
MH20587 Red with large white 
halo, almost red centered 
20 -42 through -45 
GGCC 
MH20590 Red with small white 
halo 
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Table 6 (continued). 
 
Mutation 
 
Mutation alterations Strain 
 
Colony phenotype 
21 -42 through -45 
GGGG 
MH20591 Red 
22 -57 G to T, -53 A to G 
and -31 C to T 
MH20635 Red 
23 -57 G to T and -53 A 
to G 
MH20594 Red 
24 -57 G to T and -31 C 
to T 
MH20638 Red 
25 -53 A to G and -31 C 
to T 
MH20641 Red 
26 -50 G to T 
 
MH20597 Red 
27 -48 A to T and -39 T 
to A 
MH20644 White 
28 -49 to -47 ATT and 
-40 to -38 AAT 
MH20646 White 
29 -50 to -46 TATTC  
and -40 to -38 AAT 
MH20651 White 
Positive 
Control 
Wild-type Pm MH20655 Red 
Negative 
control 
Without Pm 
 
MH20656 White 
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Figure 15. Gel shift for mutations 1, 2 and 3 
 
Mutation 1 (-46 A to C): This mutation led to red colonies with a small white halo around 
them indicating somewhat lower activity, which correlated with a β-galactosidase activity 
of 518 relative to the wild-type activity set to 1000. The gel shift for this mutation 
revealed a slightly higher binding as compared to that of the wild-type at both 
concentrations of His-Mor (400 and 800 ng). Thus, changing this A to a C is tolerated by 
the promoter without drastically changing its activity. 
 
Mutation 2 (-41 G to T): This mutation gave red colonies with a small white halo around 
them indicating lower activity which correlated with its β-galactosidase activity of 377 
relative to the wild-type activity set to 1000. The gel retardation assay with this mutation 
showed significantly lower binding as compared to the wild-type at both the 
concentrations of His-Mor (400 and 800 ng). This weak binding to the promoter DNA 
would explain its lower capacity to activate transcription from the promoter, as indicated 
by its lower β-galactosidase activity. This indicates that the G in this position is important 
for Mor binding. 
 
Mutation 3 (-48 A to C and -39 T to G): This mutation gave white colonies on 
MacConkey plates, indicating a severely defective phenotype similar to the negative 
control with a deleted promoter Pm. Mor failed to bind to the promoter DNA as seen from 
the gel shift data at levels even as high as 800 ng of protein, and this explained its almost 
undetectable β-galactosidase activity of 0.3. As wild-type His-Mor failed to bind to the 
promoter with this mutation, it could not activate transcription from that promoter as it 
could not recruit RNA polymerase to the promoter. 
 
These specific bases seem to be critical for the promoter binding and transactivation 
function of His-Mor. It also indicates that the specific bases are important for Mor 
recognition and binding rather than just symmetry because even thought this mutation 
maintained the symmetry with a G/C combination as opposed to the wild-type of A/T 
combination, yet it failed to bind His-Mor. 
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Figure 16: Gel shift for mutations 4, 5 and 6. 
 
Mutation 4 (-37 A to C): This mutant exhibited a red phenotype on MacConkey plates, 
indicating a wild-type phenotype and functionally active promoter. This was further 
justified by its His-Mor binding which was similar to the wild-type promoter at both 
concentrations of His-Mor (400 and 800 ng), and its in vivo β-galactosidase activity of 
951, that was very close to the wild-type promoter activity. Even though a symmetrical 
change was made at this position with respect to -50G centered at -43.5, it did not 
increase the binding of His-Mor. Thus, symmetry at this position may not contribute 
significantly to Mor binding and activation, as it tolerates both C and A at this position 
without much effect. 
 
Mutation 5 (-52 C to G): This mutation imparted a red phenotype with a small white halo 
around the colonies indicating a slightly lower promoter activity which correlated with its 
β-galactosidase activity of 639 relative to the wild-type activity set to 1000. The gel 
retardation assay indicated that the promoter with this mutation had the capacity to bind 
wild-type His-Mor to about 80% of the wild-type promoter at both concentrations of  
His-Mor (400 and 800 ng). This position lies just outside the Mor-binding region as 
indicated in footprinting analysis (Kahmeyer-Gabbe and Howe, 1996). Making this 
position symmetrical with respect to -35C centered at -43.5 reduced its capacity to bind 
His-Mor and gave a lower promoter activity as compared to wild-type. This indicates the 
contribution of this position to Mor binding and promoter activity. 
 
Mutation 6 (-52 C to A and -35 C to T): This double mutation imparted a red phenotype 
with a small white halo around the colonies similar to that of mutation 5, indicating a 
slightly lower promoter activity, which correlated with its β-galactosidase activity of 597 
relative to the wild-type activity set to 1000. The gel retardation assay showed that the 
promoter with this double mutation had the capacity to bind wild-type His-Mor to about 
70% of the wild-type promoter, which explains its lower level of in vivo promoter 
activity as measured in the β-galactosidase assay. This mutation and mutation 5, both 
indicate the specific contribution of -52C to Mor binding and promoter activity. Also, it is 
not the symmetry at these positions that is important for Mor binding but the presence of 
the specific bases -52C and -35C that stabilize Mor binding to Pm. 
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Figure 17: Gel shift for mutations 7, 8 and 9. 
 
Mutation 7 (-34 C to T): This mutant exhibited a red (wild-type) phenotype on 
MacConkey plates indicating a functionally active promoter. This conclusion was further 
supported by its binding to His-Mor and its in vivo β-galactosidase activity of 809, both 
of which were similar to those of wild-type promoter. Even though a symmetrical change 
was made at this position with respect to -53A centered at -43.5, it did not increase the 
binding of His-Mor. Thus, symmetry at this position may not contribute significantly to 
Mor binding and activation as it tolerates both C and T at this position without much 
effect. This position lies just outside the Mor-binding region of Pm and as expected, it 
does not significantly contribute to Mor binding. The β-galactosidase activity indicated 
that the nucleotide at this position is also not very important for RNA polymerase binding 
and that it can tolerate base changes. 
 
Mutation 8 (-53 A to G): This mutation imparted a red phenotype with a small white halo 
around the colonies similar to that of mutation 5, indicating a slightly lower promoter 
activity which correlated with its β-galactosidase activity of 630 relative to the wild-type 
activity set to 1000. The gel retardation assay indicated that the promoter with this 
mutation had the capacity to bind wild-type His-Mor to about 80% of the wild-type 
promoter which correlates with its lower level of in vivo promoter activity as measured in 
the β-galactosidase assay. This mutation also introduced a symmetrical substitution 
similar to mutation 7, but with a G/C combination as opposed to the A/T combination 
that was introduced by mutation 7 at these positions. Even though a promoter with this 
mutation binds His-Mor almost as effectively as wild-type, this position probably 
contributes to transactivation through interaction with RNA polymerase. As noted earlier, 
this position lies in the region predicted to interact with one of the α-CTD subunits of the 
RNAP (Ma and Howe, 2004). This would explain why a mutation at this position bound 
the protein but displayed a lower in vivo activity. 
 
Mutation 9 (-33 G to T): This mutation imparted a red phenotype with a small white halo 
around each colony similar to that of mutation 8, indicating a slightly lower promoter 
activity which correlated with its β-galactosidase activity of 654. The gel retardation 
assay indicated that the promoter with this mutation had the capacity to bind wild-type 
His-Mor to about 80% of the wild-type promoter which explains its lower level of in vivo 
promoter activity as measured in the β-galactosidase assay. This mutation introduces a 
symmetrical change at this position with respect to -54A. The closer-to-wild-type binding 
by His-Mor but significantly lower in vivo activity indicates that even though it lies 
beyond the Mor-binding site, -33G contributes to the activation of the promoter probably 
through its interaction with RNAP. 
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Figure 18: Gel shift for mutations 10, 11 and 12. 
 
Mutation 10 (-54 A to C): This mutation imparted a red phenotype with a larger white 
halo around the colonies similar to mutation 8, indicating a lower promoter activity which 
correlated with its β-galactosidase activity of 335. The gel retardation assay indicated that 
the promoter with this mutation had the capacity to bind wild-type His-Mor to about 85% 
of the wild-type promoter at both concentrations of His-Mor (400 and 800 ng). The in 
vivo activity due to this mutation is much lower and does not seem to be because of the 
binding effect of Mor to the promoter with this mutation. This mutation also introduced a 
symmetrical substitution similar to mutation 9, but with a G/C combination as opposed to 
the A/T combination that was introduced by mutation 9 at these positions. The closer-to-
wild-type binding by His-Mor but significantly lower in vivo activity indicates that this 
position probably contributes to the transactivation through interaction with RNA 
polymerase. As noted earlier, this position lies in the region predicted to interact with one 
of the α-CTD subunits of the RNAP, just like position -53A that was affected by 
mutation 8 (Ma and Howe, 2004). This would explain why a mutation at this position 
bound the protein but displayed a lower in vivo activity. 
 
Mutation 11 (-32 G to T):  This mutation conferred a red (wild-type) phenotype on 
MacConkey plates, indicating a functionally active promoter. Its binding of His-Mor was 
similar to that of wild-type promoter and its in vivo β-galactosidase activity of 1133 was 
slightly higher than the wild-type promoter activity. Even though a symmetrical change 
was made at this position with respect to -55A centered at -43.5, it did not increase the 
binding of His-Mor. Thus, symmetry at this position may not contribute to Mor binding 
and activation as both T and G are tolerated at this position, a finding understandable by 
the observation that this position lies outside the Mor-binding region of Pm. The higher in 
vivo activity of the promoter due to this mutation indicates the possible contribution of 
this position to activation through interaction with RNAP which is increased by 
substituting a T at this position. 
 
Mutation 12 (-31 C to A): Colonies with this mutation exhibited a red (wild-type) 
phenotype on MacConkey plates, indicating a functionally active promoter. The in vivo 
β-galactosidase activity was 1139, slightly higher than wild-type promoter activity. The 
gel shift showed a lower binding capacity of the promoter with this mutation to His-Mor; 
60% to that of the wild-type promoter at both concentrations of His-Mor (400 and 800 
ng). Even though a symmetrical change was made at this position with respect to -56T 
centered at -43.5; it did not increase the binding of His-Mor. The lower binding of His-
Mor could be an experimental artifact as this position lies well outside the Mor-binding 
region. Thus, symmetry at this position may be irrelevant to Mor binding. The higher in 
vivo activity of the promoter with this mutation indicates the possible contribution of this 
position to activation through interaction with RNAP, which is increased by substituting 
an A at this position. 
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Figure 19: Gel shift for mutations 13, 14 and 15. 
 
Mutation 13 (-56 T to A and -31 C to T): This mutation led to a red (wild-type) 
phenotype on MacConkey plates indicating a functionally active promoter. The in vivo  
β-galactosidase activity was 1272, higher than the wild-type promoter activity observed 
for -31 C to T alone. The gel retardation assay revealed similar to wild-type binding. The 
closer-to-wild-type binding by His-Mor at both concentrations (400 and 800 ng) but 
significantly higher in vivo promoter activity indicates that this position probably 
contributes to transactivation through interaction with RNA polymerase. As noted earlier, 
-56 lies in the region predicted to interact with one of the α-CTD subunits of RNAP, just 
like position -53A and -54A that were affected by mutation 8 and mutation 10 
respectively (Ma and Howe, 2004). The difference was that mutations 8 and 10 
negatively affected the promoter activity while this mutation contributed positively to 
promoter activity. This would explain why a mutation at this position bound His-Mor at 
levels similar to the wild-type promoter but displayed a higher in vivo activity. Recall that 
mutation -31 C to T alone gave a higher than wild-type promoter activity, it could 
indicate a positive contribution of the single substitution in this mutation to binding with 
the σ-CTD of the RNAP more effectively. Hence, if at all mutation -56 T to A contributes 
to promoter activity, it would have a positive effect. 
 
Mutation 14 (-57 G to T): Colonies with this mutation exhibited a red phenotype on 
MacConkey plates indicating a functionally active promoter. Its binding to His-Mor was 
similar to the wild-type promoter and its in vivo β-galactosidase activity was 902, very 
close to the wild-type promoter activity. The similarity to wild-type binding can possibly 
be explained by the observation that this position is well outside of the Mor-binding 
region of Pm. The high in vivo activity of the promoter due to this mutation indicates a 
possible contribution of this position to activation through its interaction with the RNAP 
α-CTD subunit which is increased by substituting a T at this position; correlating with the 
observation that this position lies in the region predicted to interact with one of the  
α-CTD subunits of the RNAP (Ma and Howe, 2004). This would explain why a mutation 
at this position bound the protein but displayed a high in vivo activity. 
 
Mutation 15 (-57 G to T and -30 T to A): This mutation imparted a red phenotype with a 
small white halo around the colonies, indicating somewhat lower promoter activity than 
the wild-type, which correlated with its β-galactosidase activity of 647. The gel 
retardation assay indicated that the promoter with this mutation had the capacity to bind 
wild-type His-Mor to about 80% of the wild-type promoter at both concentrations of  
His-Mor (400 and 800 ng) which partially explains its lower level of in vivo promoter 
activity as measured in the β-galactosidase assay. The closer-to-wild-type binding by 
His-Mor but significantly lower in vivo activity indicates that these positions contribute to 
the activation of the promoter probably through its interaction with RNAP. Since 
mutation 14 indicated the contribution from the individual substitution at -57 which gave 
a wild-type activity, the effect of this double substitution is probably due to the 
contribution of the -30 position. Changing the -30 T to A reduces the promoter activity, 
probably indicating an important contribution of the -30T to RNAP interaction through 
its σ-CTD subunit which binds to this region of the promoter. 
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Figure 20: Gel shift for mutations 16 and 17. 
 
Mutation 16 (-50 G to T and -41 G to T): This mutation imparted a red phenotype with a 
small white halo around the colonies indicating a lower activity, which correlated with its 
β-galactosidase activity of 421. The gel retardation assay with this mutant gave only 
about 50% of the wild-type promoter binding to His-Mor at both concentrations of  
His-Mor (400 and 800 ng). This weak binding to the promoter DNA would explain its 
lower capacity to activate transcription from the promoter indicated by almost 60% 
reduction in β-galactosidase activity. It indicates the importance of the nucleotides in 
these positions for Mor binding. Even though the 6-bp segments that bind Mor were 
made perfectly symmetrical to each other with an increased AT-rich sequence, binding 
was negatively affected by the mutations, indicating that Mor binding to promoter DNA 
in this region depends on specific bases and not the symmetry factor in binding the two 
monomers of the Mor dimer. When compared to the effect of the single substitutions at 
these positions, mutation 2 (-41 G to T) and mutation 26 (-50 G to T) both of which 
reduced Mor binding to promoter DNA, the effect of this mutation seems to be the 
combined effect of the two single mutations.  
 
Mutation 17 (-50 G to T and -46 A to C): This double mutation imparted a red phenotype 
with a small white halo around the colonies, indicating a slightly lower than wild-type 
promoter activity which correlated with its β-galactosidase activity of 671. The in vitro 
binding assay for this mutation was noteworthy in the fact that it repeatedly gave 
significantly higher binding by His-Mor (almost three times the binding as compared to 
the wild-type promoter). These mutations make the 6-bp segments perfectly symmetrical 
to each other and it is these segments on either side of the spacer GCCG that binds the 
two monomers of the Mor dimer. Mor binding to the promoter with this double mutation 
imparts a high level of stability to the Mor-Pm complex indicated by the dramatically 
higher binding in the gel shift assay. The hypothesis that increased Mor binding would 
increase the promoter activity is refuted in this case. Since Mor recruits the RNAP to Pm, 
the interactions between Mor and RNAP should be optimum for efficient recruitment of 
RNAP to the promoter and also optimum for the release of σ70 during promoter 
clearance and transcription elongation by the core RNAP. The higher binding of Mor 
might interfere with the efficient release of σ70 during promoter clearance by lowering its 
dissociation from the promoter. This might possibly explain why this mutation gave 
higher binding with His-Mor but lower in vivo β-galactosidase activity.  
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Figure 21: Gel shift for mutations 18 and 19. 
 
Mutation 18 (-42 through -45 AAAA): This mutation led to red colonies with a small 
white halo around them indicating lower promoter activity which correlated with its  
β-galactosidase activity of 539. The gel retardation assay with this mutant promoter 
showed significantly lower binding, only 40 % as compared to the wild-type promoter. 
This weak binding to the promoter DNA would explain its reduced ability to activate 
transcription from the promoter as indicated by its lower β-galactosidase activity. Since 
side chains of Q68 and Y70 from the β-strand of Mor are proposed to interact with the 
minor groove, these nucleotides in the minor groove may be important for Mor binding. 
The A-rich sequence may change the dimensions of the minor groove altering the 
stereochemistry of Mor interactions within the minor groove and the two major grooves 
on either side. 
 
Mutation 19 (-42 through -45 TAAT): This mutation resulted in red colonies with large 
white halos, indicating lower promoter activity consistent with a β-galactosidase activity 
of 344. In the gel retardation assay, this mutation led to significantly lower Mor binding 
(∼40%) as compared to the wild-type. The weak binding of His-Mor to the promoter 
DNA with this mutation would explain its reduced transcription activity. Since side 
chains of Q68 and Y70 from the β-strand of Mor are proposed to interact with the minor 
groove, these bases in the minor groove may be important for Mor binding. The A-rich 
sequence may change the dimensions of the minor groove, altering the stereochemistry of 
Mor interactions at the minor groove and in the two major grooves on either side. 
 
The effect of the mutations 18 and 19, which make the minor groove spacer  
AT-rich, indicates the preference for GC-rich sequences in the region. Thus it is not the 
symmetry in this spacer that is important, but the presence of GC-rich sequences. 
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Figure 22: Gel shift for mutations 20 and 21. 
 
Mutation 20 (-42 through -45 GGCC): The mutant with these substitutions gave red 
colonies with small white halos around them indicating slightly lower promoter activity 
which correlated with its β-galactosidase activity of 618. The gel shift for this mutation 
revealed a lower binding, of about 60% as compared to that of the wild-type at both the 
concentrations of His-Mor used (400 and 800 ng). Thus the lower promoter activity due 
to this mutation is possible because of the reduced binding of His-Mor. The difference in 
the in vivo activity correlates with the difference in the binding of His-Mor at the 
promoter with this mutation. The fact that this mutation maintains the GC-richness of the 
minor groove spacer but significantly reduces binding by His-Mor indicates that it is not 
the GC-richness alone, but the specific bases in the minor groove that are important. The 
symmetry introduced by the wild-type may be important for Mor binding.  
 
Mutation 21 (-42 through -45 GGGG): This mutation imparted a red (wild-type) 
phenotype to the colonies on MacConkey plates indicating a functionally active 
promoter. This was consistent with its binding, which was similar to the wild-type 
promoter at both the concentrations of His-Mor used (400 and 800 ng) and it’s in vivo  
β-galactosidase activity of 768. The lower β-galactosidase activity may indicate the 
importance of these bases in the minor groove. 
 
Recall that most of the base substitutions in the minor groove gave red colonies on 
MacConkey plates; leading to the conclusion that the bases may not contribute 
significantly to Mor binding and function. Comparing mutations 18 and 19 with 
mutations 20 and 21 indicates that a somewhat GC-rich sequence may be preferred in the 
minor groove spacer, though a mutation to AT-rich sequences does not very drastically 
change the activity. Comparing mutation 20 and 21 in terms of their binding and  
β-galactosidase activity, it is possible that the outer G’s might be more important than the 
inner C’s of the GCCG spacer. Even though minor groove interactions appear to be  
important for Mor binding, mutations of the bases in the minor groove do not affect Mor 
binding as much mutations of the amino acids Q68 and Y70 (Kumaraswami, 2005). 
Hence the amino acids probably interact with the minor groove spacer in a base  
non-specific manner. 
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Figure 23: Gel shift for mutations 22 and 23. 
 
Mutation 22 (-57 G to T, -53 A to G and -31 C to T): The mutant with these base changes 
mutation exhibited a red phenotype on MacConkey plates indicating it has a functionally 
active promoter. This conclusion was further supported by its His-Mor binding to a level 
similar to that of the wild-type promoter and an in vivo β-galactosidase activity of 1021, 
which was close to the wild-type promoter activity. Even though the single mutations 
individually at these positions recorded a high β-galactosidase activity, the effect is not 
cumulative as indicated from the triple mutation. The similarity to wild-type binding can 
possibly be explained by the fact that all three bases changed are outside of the  
Mor-binding region of Pm. The high in vivo activity of the promoter due to this mutation 
indicates the possible contribution of these positions to activation through interaction 
with RNAP. Even though a promoter with these mutations binds His-Mor as effectively 
as wild-type, these positions probably contribute to the transactivation through interaction 
with RNA polymerase. As noted earlier, these positions lie in the region predicted to 
interact with RNAP; -53 and -57 are in the region of the promoter predicted to interact 
with one of the α-CTD subunits of the RNAP and -31 is in the region that interacts with 
σ-CTD of the RNAP (Artsimovitch and Howe, 1996). This would explain why a 
mutation at this position bound the protein as efficiently as wild-type promoter and 
displayed a high in vivo activity. 
 
Mutation 23 (-57 G to T and -53 A to G): This mutation conferred a red phenotype on 
MacConkey plates indicating a functionally active promoter. This was further supported 
by its binding assay which showed similarity to wild-type promoter. The in vivo  
β-galactosidase activity was lower than the wild-type, only 642 relative to the wild-type 
of 1000. The similar to wild-type binding can possibly be explained by the observation 
that this position is outside of the Mor-binding region of Pm. Even though a promoter 
with these mutations binds His-Mor as effectively as wild-type, the low in vivo activity of 
the promoter due to this mutation indicates the possible contribution of these positions to 
activation through interaction with RNAP. As noted earlier, these positions lie in the 
region predicted to interact with RNAP; -53 and -57 are in the region of the promoter 
predicted to interact with one of the α-CTD subunits of the RNAP (Ma and Howe, 2004). 
This would explain why this mutation bound the protein as efficiently as the wild-type 
promoter but displayed a lower in vivo activity. 
 
Comparing mutations 22 and 23, the higher promoter activity of mutation 22 is probably 
due to contribution from -31T which is in the region interacting with σ-CTD of the 
RNAP than the other two (-57 G to T and -53 A to G).  
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Figure 24: Gel shift for mutations 24 and 25. 
 
Mutation 24 (-57 G to T and -31 C to T): This mutation imparted a red phenotype to the 
colonies on MacConkey plates indicating a functionally active promoter. The in vivo  
β-galactosidase activity was 1272, that was higher than the wild-type promoter activity as 
observed for -31 C to T. The gel retardation assay revealed a similarity to wild-type 
binding. The closer-to-wild-type binding by His-Mor at both the concentrations (400 and 
800 ng) but significantly higher in vivo activity indicates that these positions probably 
contribute to transactivation through interaction with RNA polymerase. These positions 
lie in the region predicted to interact with RNAP subunits; position -57 is in the region of 
the promoter predicted to interact with one of the α-CTD subunits of the RNAP and 
position -31 is the region that is predicted to interact with σ-CTD of the RNAP 
(Artsimovitch and Howe, 1996; Ma and Howe, 2004). This would explain why mutation 
at these positions bound the protein as efficiently as wild-type promoter but displayed a 
significantly higher in vivo activity. Comparing this with mutations 22 and 23 also 
indicates the significant contribution of the -31T to promoter activity. 
 
Mutation 25 (-53 A to G and -31 C to T): This mutation conferred a red phenotype to 
colonies on MacConkey plates indicating a functionally active promoter which correlated 
with the in vivo β-galactosidase activity of 816, which was close to the wild-type 
promoter activity. The gel retardation assay revealed a similarity to wild-type binding. 
The closer-to-wild-type binding by His-Mor at both the concentrations of His-Mor (400 
and 800 ng) but slightly lower in vivo activity indicates that these positions probably 
contribute to the transactivation through interaction with RNA polymerase. These 
positions lie in the region predicted to interact with RNAP; -53 is in the region of the 
promoter predicted to interact with one of the α-CTD subunits of the RNAP and the -31 
is the region that interacts with σ-CTD of the RNAP (Artsimovitch and Howe, 1996; Ma 
and Howe, 2004). This would explain why a mutation at this position bound the protein 
as efficiently as wild-type promoter but displayed a slightly lower in vivo activity. 
Comparing the in vivo promoter activity due to 1) mutation 25 and mutation 23 and 2) 
mutation 25 with mutations 22 and 24, there is an indication of a significant contribution 
of -31T to promoter activity than that of the other 3 positions. 
 
Comparison of mutations 22 through 25 with mutation 14 (-57 G to T) indicates a 
significant contribution by -57T though not as much as that by -31T. Comparing these 
mutations with mutation 13 (-56 T to A and -31 C to T) also underlines the previous 
observation. Comparing these with mutation 8 (-53 A to G), there is an indication that the 
contribution by -53A is not as significant as those of the other two (-57T and -31T). 
The observation that mutations 22 through 25 showed His-Mor binding similar to  
wild-type promoter, but variations in their in vivo activity also alludes to the possibility 
that mutations in these positions do not affect binding by Mor, but affect transcription 
activation though interaction with the RNAP subunits. 
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Figure 25: Gel shift for mutation 26. 
 
Binding experiments with mutation 1 and mutation 17 on this gel were done to test the 
reproducibility of the higher binding of His-Mor to the promoter with these mutations 
and it was found to be so. 
 
Mutation 26 (-50 G to T): This mutation conferred a red phenotype to the colonies on 
MacConkey plates indicating a functionally active promoter. This was further supported 
by its binding to His-Mor, which was just slightly lower to that of wild-type promoter and 
its in vivo β-galactosidase activity of 863, that was also slightly lower than the wild-type 
promoter activity. This mutation was designed to test the individual contribution by -50T 
to mutation 17 (-50 G to T and -46 A to C), as mutation 17 gave twice the wild-type 
binding by His-Mor in a gel shift in vitro binding assay. Base change -46C contributes 
significantly to mutation 17 as seen from binding with mutation 1 (-46 A to C), but 
contribution by the individual mutation -50 G to T is not significant. It might be that the 
combination of -50T and -46C, which made the 6-bp segments on either side of the 4-bp 
spacer (-42 through -45) is what makes it bind so efficiently to His-Mor by highly 
stabilizing the Mor-Pm complex. Thus, the specific bases in the region of Mor binding are 
important rather than the factor of symmetry as indicated by comparing mutations 16 and 
17, which both made the segments perfectly symmetrical, though using different 
substitutions. 
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Figure 26: Gel shift for mutations 27, 28 and 29. 
 
Mutation 27 (-48 A to T and -39 T to A): This mutation imparted white color to the 
colonies on MacConkey plates indicating a severely defective phenotype similar to the 
mutant with a deleted promoter. His-Mor failed to bind to the promoter DNA with this 
mutation at levels even as high as 800 ng of protein, as seen from the gel shift data and 
this explained its almost undetectable β-galactosidase activity of 0.5. It also indicates that 
the bases are important for Mor recognition and binding and it is not just the symmetry 
element because even thought we maintained the symmetry by swapping the nucleotides 
between these positions in the already symmetrical wild-type promoter, it failed to bind 
His-Mor. 
 
Mutation 28 (-49 to -47 ATT and -40 to -38 AAT): This mutation also led to white 
colonies on MacConkey plates indicating a severely defective phenotype similar to the 
mutant with a deleted promoter. His-Mor failed to bind to the promoter with this 
mutation at levels even as high as 800 ng of protein DNA, as seen from the gel shift data 
and this explained its almost undetectable β-galactosidase activity of 0.8. It also indicates 
that the bases are important for Mor recognition and binding and it is not just the 
symmetry element because even thought we maintained the symmetry by swapping the 
segments between these positions in the already symmetrical wild-type promoter, it failed 
to bind His-Mor. Thus, the bases in these segments seem to be extremely critical for 
binding with Mor as it does not tolerate any changes as shown by mutations 27, 28 and 3 
(-48 A to C and -39 T to G). 
 
Mutation 29 (-50 to -46 TATTC and -40 to -38 AAT): This mutation also led to white 
colonies on MacConkey plates indicating a severely defective phenotype similar to the 
mutant with a deleted promoter. His-Mor failed to bind to the promoter DNA with this 
mutation at levels even as high as 800 ng of protein, as seen from the gel shift data and 
this explained its almost undetectable β-galactosidase activity of 0.8. This mutation is a 
combination of mutation 28 (-49 to -47 ATT and -40 to -38 AAT) and mutation 17 (-50 
G to T and -46 A to C). Even though mutation 17 bound His-Mor extremely efficiently, 
mutation 29 failed to do so indicating the significant contribution of the segments -49 to  
-47 TAA and -40 to -38 TTA to mutation 17. It is not just -50T and -46C of mutation 17 
that contributes to its high binding, but it is the effect of the mutations in combination 
with the other bases in the 6-bp segment on either side of the 4-bp spacer. 
 
The analysis of the mutations 3, 27, 28 and 29 together reveal the critical role played by 
the specific bases in the Mor-binding region of Pm which lie as 2 imperfectly inverted 
symmetrical elements on either side of the 4-bp spacer. They also indicate that it is the 
presence of the specific bases in these positions that are important for Mor binding and 
not just the factor of symmetry at these positions. As wild-type His-Mor failed to bind to 
the promoter with these mutations, it could not activate transcription from that promoter 
as it could not recruit RNA polymerase to the promoter. These specific bases seem to be 
critical for the promoter binding and function of His-Mor. 
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The length of the double-stranded oligonucleotides optimum for Mor binding 
 
Different length oligonucleotides were designed starting with an 18-mer centered 
at -43.5. Then two nucleotides were added corresponding to their positions in Pm, one on 
either side of the 18-mer to obtain other oligonucleotides in the series: 20-mer, 22-mer, 
24-mer, 26-mer, 28-mer and 30-mer. The list of the oligonucleotides used for this 
experiment is given in Table 4. All the bottom strand oligonucleotides were radioactively 
labeled with γ-P32 ATP, and gel shift reactions were set up with each double-stranded 
pair, assaying with wild-type His-Mor binding at varying concentrations: 200 ng, 400 ng 
and 800 ng. This experiment was done to identify the lowest length that would give an 
optimum gel shift. The rationale behind designing the different length oligonucleotides 
and using different levels of protein is as follows: there is a possibility that a shorter 
length oligonucleotide which would fail to bind detectably to His-Mor at lower 
concentrations, could bind His-Mor at higher protein concentrations, giving a detectable 
shift in the assay. In contrast, it would help us determine the lowest concentration of 
protein which would give an optimum detectable shift with longer oligonucleotides. This 
can also be used as an indicator to determine the most critical bases that define Mor-
promoter DNA interactions and the minimum length of the oligonucleotide needed to 
produce a detectable shift in the assay. 
 
The pictures of the gels of this experiment are given in Figure 27. The following 
observations were made from this experiment: 
 
1. His-Mor failed to shift the 16-mer oligonucleotide duplex, probably because its 
length is not sufficient for protein binding or that the double-stranded DNA 
complexes and/or the His-Mor DNA complexes are unstable, hence undetectable 
at experimental conditions. 
2. All other length oligonucleotides bound His-Mor at all three protein levels used, 
with minor differences.  
3. At the levels of His-Mor protein used, increasing amounts of the protein gave 
increasing intensities of bound probe, giving a gradually increasing gradient from 
200 ng to 400 ng to 800 ng. 
4. All the probes from at least a 22-mer and increasing to the 30-mer showed 
similarity in their binding to the protein with no observable differences.  
5. The capacity of binding of the 18-mer probe to the protein was lower than all 
other size oligonucleotides at the three levels of protein used, indicating that even 
though the binding of His-Mor to the 18-mer is detectable, this interaction is 
probably more stable and/or more detectable in longer oligonucleotides. 
 
In order to study the effect of mutations in the context of a longer stretch of Pm, 
the 30-mer oligonucleotide was used for the study of mutations from -57 to -30 of Pm. 
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Figure 27: Gel shifts with different size oligonucleotides. 
 
A Gel shift with 18, 20 and 22-mer oligonucleotides 
B Gel shift with 22, 24 and 26-mer oligonucleotides 
C Gel shift with 26, 28 and 30-mer oligonucleotides 
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Test whether Mor binding stabilizes the duplex oligonucleotide 
 
For this experiment, the combined mutation -50T and -46C that gave the highest 
binding to Mor were used. The hypothesis was that if this interaction between Mor and 
DNA stabilizes the duplex, then we would get detectable and good shift in the assay with 
shorter length oligonucleotides and/or at lower reaction times. For this a 16-mer, 18-mer 
and 20-mer with the combined mutations -50T and -46C within the promoter, Pm were 
used with wild-type His-Mor at 200 ng and 400 ng amounts and the reaction was set up at 
three time points: 10, 20 and 30 min.  
 
The pictures of the gels of this experiment are given in Figure 28. The following 
observations were made from this experiment: 
 
1. The 16-mer and 18-mer did not show detectable His-Mor binding at both the 
protein levels and at all the time points. 
2. The binding of His-Mor to the 20-mer at 10 min reaction time was barely 
detectable. 
3. At 400 ng of protein, the 20-mer was detectably bound after 20min reaction time 
and the level of binding increased at the 30 min time point. 
4. The same trend was observed with 200 ng of protein as with 400 ng though at 
lower intensities. 
5. The control 30-mer bound very efficiently to His-Mor even at 200 ng protein 
level and as early as 10 min incubation time, and the amount of bound probe 
increased with an increase in the reaction incubation time. 
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Figure 28: Gel shift to test Mor-oligo duplex stability. 
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Chapter 3: Summarized results and discussion 
 
 
The results of plate phenotyping, in vivo transactivation assays and in vitro 
binding assays for all the specific mutations are presented in Table 7. For the 
convenience of understanding, positions -30 to -57 of Pm promoter is divided into three 
regions: the 4-bp minor groove spacer region, the 6-bp dyad-symmetry sequences and the 
region flanking the Mor-binding sequences of Pm.  
 
 
Results of the spacer region mutations (Figure 29) 
 
About 60 mutants isolated with mutations in the spacer region gave red colonies, 
indicating a wild-type phenotype. Functionally these can be classified as wild-type or at 
least close-to-wild-type. Two GC-rich mutants were chosen for further analysis. GGGG 
gave red colonies while CCGG had given an almost wild-type phenotype. In addition, 
two more AT-rich mutants were isolated by targeted mutagenesis and analyzed further. 
The AAAA mutation gave colonies which were red with a small white halo while the 
TAAT mutation imparted almost a red-centered phenotype to the colonies. The β-
galactosidase activities recorded for these mutants correlated with their phenotypes. The 
red one had almost wild-type activity; the reds with a small white halo gave less than 
wild-type activity and the red centered one had less than half of the wild-type activity. 
None of the 60 isolated mutants imparted a severely defective phenotype or completely 
abolished Mor binding. However, a clear gradation was seen with respect to Mor binding 
and in vivo activity in the four mutations tested for them. This indicates that even though 
the specificity of the bases in the 4-bp spacer region 5’ GCCG 3’ is not stringent, the 
effect of mutagenesis of this region is detectable. Comparing this with the effect of 
mutagenesis in the bases of the major groove of the Mor-binding site, it can be stated that 
even though the minor grove bases do contribute to facilitate Mor binding, they are not as 
important as the major groove bases. Thus, major groove interactions of Mor with DNA 
play a major role at the promoter and the minor groove has a minor contribution. 
 
 
Results of the mutations in the Mor-binding segments of the promoter (Figure 30) 
 
The bases TAA in the positions -49, -48 and -47  and their symmetrical positions 
occupied by bases TTA in positions -40, -39 and -38 are very interesting in the fact that 
they do not tolerate any base changes. These positions are perfectly symmetrical in the 
natural promoter; the bases and perhaps the symmetry in these positions seem to play a 
major role in strengthening Mor-DNA interactions. This was supported by the 
observation that any mutations in these positions exhibited a severe defect in Mor binding 
and hence activation of Pm. 
 
In this study, no mutagenesis was attempted in the positions -51 and -36 of Pm as 
any mutations in these positions were previously found to be severely defective in 
activation by Mor (Artsimovitch, 1996). 
 93
Table 7: Summarized results of mutants: phenotypes, β-gal values and gel shift assays. 
 
Mutation 
number 
Mutation Phenotype β-gal 
value 
Gel shift 
assay 
1 -46 A to C Red with small white 
halo 
518 +++++ 
2 -41 G to T Red with small white 
halo 
377 ++ 
3 -48 A to C and 
-39 T to G 
White 0.4 - 
4 -37 A to C Red 951 +++++ 
5 -52 C to G Red with small white 
halo 
639 ++++ 
6 -52 C to A and 
-35 C to T 
Red with small white 
halo 
597 +++ 
7 -34 C to T Red 809 ++++ 
8 -53 A to G Red with small white 
halo 
630 ++++ 
9 -33 G to T Red with small white 
halo 
654 ++++ 
10 -54 A to C Red with larger white 
halo than others 
335 ++++ 
11 -32 G to T Red 1133 ++++ 
12 -31 C to A Red 1139 ++++ 
13 -56 T to A and 
-31 C to T 
Red 1272 +++++ 
14 -57 G to T Red 902 +++++ 
15 -57 G to T and 
-30 T to A 
Red with small white 
halo 
647 +++ 
16 -50 G to T and 
-41 G to T 
Red with small white 
halo 
421 +++ 
17 -50 G to T and 
-46 A to C 
Red with small white 
halo 
671 ++++++++++
18 -42 through  
-45 AAAA 
Red with small white 
halo 
539 ++ 
19 -42 through  
-45 TAAT 
Red with large white 
halo, almost red 
centered 
344 ++ 
20 -42 through  
-45 GGCC 
Red with small white 
halo 
618 +++ 
21 -42 through  
-45 GGGG 
Red 768 +++++ 
22 -57 G to T, -53 
A to G and -31 
C to T 
Red 1021 +++++ 
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Table 7 (continued). 
 
 
β-gal Value standardized to the wild-type set as 1000. 
+++++ is wild-type binding. 
++++ is 75 to 90% of wild-type. 
+++ is 50 to 75% of wild-type. 
++ is 30 to 50% of wild-type. 
++++++++++ is very high binding almost 200% of wild-type binding. 
- is no detectable binding similar to the negative control. 
 
 
 
 
 
 
 
Mutation 
number 
Mutation Phenotype β-gal 
value 
Gel shift 
assay 
23 -57 G to T and 
-53 A to G 
Red 642 +++++ 
24 -57 G to T and 
-31 C to T 
Red 1488 +++++ 
25 -53 A to G and 
-31 C to T 
Red 816 +++++ 
26 -50 G to T Red 863 +++ 
27 -48 A to T and 
-39 T to A 
White 0.5 - 
28 -49 to -47 
ATT and 
-40 to -38 
AAT 
White 0.8 - 
29 -50 to -46 
TATTC and 
-40 to -38 
AAT 
White 0.8 - 
Positive 
Control 
with 
wild-type 
Pm 
No mutation Red 1000 +++++ 
Negative 
control 
without 
Pm 
Deletion of Pm White 5 - 
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Figure 29: Summarized results of the spacer region mutations. 
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Figure 30: Summarized results of the mutations in the Mor-binding segments of the 
promoter. 
 
Binding assay values are a percent of wild-type binding. 
β-gal values are with respect to wild-type set to 1000. 
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Base changes are also not tolerated at -41G, as any mutation at this position gave 
weaker Mor binding and hence lower activation of Pm. 
 
Base changes at the symmetrical positions -37A and -50G did not affect Mor 
binding and promoter activity. These positions lie just within the imperfect dyad 
symmetry, and they do not seem to play as significant a role in Mor-promoter interactions 
as the other bases of the dyad symmetrical elements. 
 
Positions -46A and -41G do contribute to Mor binding; mutation at -46 gave a 
significantly higher Mor binding, while mutation at -41 negatively affected Mor binding. 
These positions lie just outside the 4-bp spacer region and just within the dyad 
symmetrical elements of the Mor monomer binding sites. 
 
Mutations -50T and -46C together and -46C alone exhibited a remarkable binding 
capacity to Mor, emphasizing the importance of these positions. This observation may be 
useful while trying to crystallize Mor-DNA binary complexes to understand structural 
aspects of their interactions. Surprisingly, this mutation gave a lower level of promoter 
activity. Since Mor is proposed to recruit RNAP to the promoter through interactions 
with the α-CTD and σ70 (Artsimovitch and Howe, 1996; Ma and Howe, 2004), 
strengthening of Mor-DNA interactions may strengthen Mor-RNAP interactions; this 
may negatively affect release of σ70 during promoter clearance. Thus, the interactions 
between Mor and DNA should be optimum not only to recruit RNAP to the promoter but 
also for the subsequent release of RNAP subunits to facilitate transcription. This fact 
leads to the hypothesis that Mor binds the promoter to direct and recruit RNAP to the 
promoter and subsequently has to be released from the DNA as transcription begins. 
 
A majority of the activators influence the recruitment of RNAP in the 
transcription initiation. The activators either increase RNAP binding to the promoter or, 
when it is already bound, influence isomerization from the closed to open promoter 
complex. For example, CAP increases the initial binding of RNAP at the lac promoter, 
and λcI protein positively influences the rate of isomerization at the λPRM promoter. A 
few activators have also been shown to act at a post-recruitment step of transcription 
initiation, as observed in the case of Arc, which enhances promoter clearance from the 
Pant promoter of bacteriophage P22 during late lytic growth. A given activator can also 
influence different steps of transcription initiation in different promoters. Most of the 
CAP-dependent promoters are regulated at the RNAP recruitment step; however, at the 
malT promoter, CAP enhances promoter clearance. Using the CAP and mutant lac 
promoter, it has been demonstrated that regulatory proteins could act as activators or 
repressors in different steps of the transcription initiation pathway, depending on the 
energetic differences of the intermediate complexes. In the vast repertoire of transcription 
activators, there are few that act at multiple steps of transcription initiation at a single 
promoter. The most well known example is CAP-mediated activation of the initial 
binding of RNAP and subsequent isomerization at the gal P1 promoter. Recruitment of 
RNAP and subsequent promoter clearance at the λPR promoter are enhanced by DnaA. 
Fis has been reported to sequentially stimulate transcription initiation steps at the tyrT 
promoter by facilitating initial binding of RNAP, unwinding of DNA at the transcription 
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start point, and subsequent promoter clearance. At the PRE promoter of the λphage, cII 
protein enhances both the formation and stability of the RNAP-promoter open complex. 
Transactivator C protein of phage Mu acting at the late promoter Pmom has also been 
indicated to belong to a small group of activators acting at multiple steps of promoter-
polymerase interactions in a single promoter (Chakraborty and Nagaraja, 2006). Thus, 
based on the above observation, Mor could belong to the group of transcriptional 
activators affecting multiple steps of promoter-polymerase interactions at promoter Pm 
including its effect on promoter clearance. 
 
 
Results of the mutations in the region beyond Mor-binding segments of the 
promoter (Figures 31, 32 and 33) 
 
Positions -52 and -35 of Pm do contribute to Mor binding as well as promoter 
activity, indicating that these positions have a contribution to Mor binding as they lie just 
outside the Mor-binding sites on either side. 
 
Positions -57 through -53 which lie upstream of the Mor-binding site and 
positions -34 through -30 which are downstream of the Mor-binding site do not have a 
dramatic effect on Mor binding, but they do affect promoter activity. The observation that 
mutations in this region affect promoter activity may reflect a contribution of these 
regions in atypical interaction with the subunits of RNAP. 
 
The region -29 to -33 was previously predicted to overlap the region that 
undergoes a structural change in the form of a distortion which confers flexibility to the 
DNA and is probably necessary for the precise alignment of Mor and RNAP. The fact 
that this region may occur in the Mor-RNAP interface also raises the possibility of a 
contribution of this region to promoter activity by affecting either Mor-RNAP 
interactions or RNAP-DNA interactions (Artsimovitch and Howe, 1996). 
 
Bases -57 to -54 lie in the region that was previously predicted to be the UP-like 
element on the promoter distal side of the Mor-binding site (Ma and Howe, 2004). The 
results of mutagenesis of this region is consistent with the prediction that one of the α-
CTD subunits of RNAP interacts with this region, and the effect of mutations in this 
region to promoter activity is probably due to this interaction, which is either 
strengthened or weakened depending on the type of base changes in these positions (Ma, 
2004). The observation that positions -53 and -54 contribute more than positions -56 and 
-57 is also consistent with the previous observations (Ma, 2004). 
 
Thus, region -57 to -30 of Pm is important for activity of the promoter either 
directly or indirectly (Figure 34). The direct effect of the spacer region and the imperfect 
dyad symmetrical element and the bases just flanking them is revealed from Mor-binding 
experiments. The indirect contribution of the positions beyond the Mor-binding site on 
either side can be hypothesized from activity assays and previous observations and 
predictions for their involvement in interactions with the RNAP subunits or their 
predicted effects on conformational changes in this region. 
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Figure 31: Summarized results of mutations at positions just flanking the Mor-binding 
segments. 
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Figure 32: Summarized results of mutations at positions beyond the Mor-binding 
segments. 
 
Binding assay values are a percent of wild-type binding. 
β-gal values are with respect to wild-type set to 1000. 
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Figure 33: Summarized results of additional mutations. 
 
Binding assay values are a percent of wild-type binding. 
β-gal values are with respect to wild-type set to 1000. 
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1. Contributes to Mor binding in the minor groove spacer region, but not as critical as 
major groove bases.
2. Extremely critical for Mor binding in the major groove, no mutations are tolerated.
3. Critical major groove bases for interaction with Mor; coincides with the dyad 
symmetry Mor-binding segments.
4. Some contribution to Mor binding, and some to interaction with RNAP
a) probably with σ subunit of RNAP
b) probably with α-CTD of RNAP
5. Contributes to interaction with RNAP subunits
a) probably with σ subunit of RNAP
b) probably with α-CTD of RNAP
General conclusions from Pm mutagenesis
1 22 5a
4b 4a
3 3
5b
 
Figure 34: General conclusions from mutagenesis of the middle promoter. 
 
The regions are color coded with the font colors corresponding to the colors of the 
segments marked. Bases from -30 to -57 upstream of the transcription start site are given 
with their numbers given above the bases. 
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Major findings from the current work 
 
The findings describe the impact of this work on our understanding of Mor-Pm 
interactions. 
 
1. Demonstrated some contribution of the minor groove spacer region to Mor 
binding. 
2. Identified positions extremely critical for Mor interactions at the promoter. 
3. Identified positions that have a modest contribution to interaction with activator 
Mor. 
4. Predicted positions of the promoter that affect transactivation. This could be 
through direct interaction with RNAP subunits or through indirect conformational 
changes. 
5. Higher affinity binding of Mor to promoter correlates with reduced promoter 
activity probably due to ineffective promoter clearance. This indicates a dual role 
for activator Mor at the promoter: recruitment of RNAP to the promoter and 
release of core RNAP during promoter clearance and transcription initiation. 
 
 
Future directions 
 
The following possible experiments are proposed to dissect the protein-protein 
and protein-DNA interactions between Mor, Pm, and the different subunits of RNA 
polymerase and to define their respective roles in middle promoter regulation. 
 
1. To identify amino acid positions of Mor that interact with regions of promoter. 
2. To investigate and further understand interactions between RNAP subunit and 
promoter positions. 
3. To find out whether positions beyond Mor-binding region directly contribute to 
RNAP subunit interactions or indirectly contribute by affecting conformational 
changes at Mor-DNA-RNAP interfaces.  
4. In most cases, protein-protein contacts between the activator and different 
subunits of RNAP, mainly the α-CTD, are the basis for transcription activation 
(Dove et al, 2000). The role of protein-protein contacts between Mor-α-CTD and 
Mor-σ-CTD in the efficient recruitment of RNAP to Pm and in Mor-dependent Pm 
activation is well established (Artsimovitch et al, 1996).  A structure-guided 
targeting of the side chains of specific residues of Mor can be carried out to 
identify the RNAP contact sites in Mor. As indicated by structural homology, Mor 
binds to the major groove using primarily the residues from the tip of the 
recognition helix, α5. When Mor binds to DNA in an “ends-on mode”, two 
regions of the protein would be in close proximity to the C-terminal domains of α 
and σ of RNAP. The amino acid side chains on the external face of preceding 
helix α4. In ends-on mode of base recognition, the body of the preceding helix is 
left out of the major groove and solvent-exposed. Contacts involving minimal 
protein-protein interface is not uncommon in activator-RNAP contacts. Another 
characteristic feature of ends-on DNA-binding is that most of the C-terminal part 
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of recognition helix sticks out of the major groove and away from DNA. The 
basic-rich C-terminal tail of Mor presents an ideally located surface for 
electrostatic interactions between Mor and different subunits of RNAP. The 
frequency of the defective phenotypes in the mutant library might not be as 
drastic as it is seen in case of residues that are predicted to be involved in base-
specific interactions. So isolation of phenotypically selected mutations and a 
detailed functional characterization of the mutant proteins would be necessary to 
define their role in protein-protein contacts, thereby transcription activation. 
5. To test the prediction between inverse correlation between affinity of Mor binding 
and effective promoter clearance. 
6. UV-photo cross-linking and mass spectrometry: Identification of the specific 
contacts between Mor with middle promoter is essential to understand the basis 
for the promoter recognition. Interaction between DNA-binding proteins and their 
binding site generally involves a combination of base-specific interactions and 
non-specific interactions with phosphate backbone and sugar. The sequence-
specific DNA-binding proteins, such as Mor, discriminate their binding site from 
a vast majority of random sequences by specific interactions, whereas the non-
specific interactions provide the stability to the binary complex. UV-photo cross-
linking in tandem with mass spectrometry have emerged as a useful tool in the 
identification of specific interactions. The technique generally involves UV cross-
linking of DNA with modified bases to the side chains of amino acids it interacts 
with. UV irradiation of derivatized nucleobases such as 5’-iodouracil generates 
highly reactive intermediates that form zero-length cross links to the amino acid 
side chains in the vicinity. This covalently cross-linked heteroconjugates can be 
subjected to protease digestion and/or nuclease digestion to reduce the size of the 
peptide or nucleotide fragments. The purified fragments can be analyzed on a 
Matrix-Assisted Laser Desorption/Ionisation Time-Of-Flight Mass Spectrometry 
(MALDI-TOF MS). 
7. Findings can be used to optimize the positions of the promoter with respect to 
those that affect Mor-binding and α-CTD-binding for crystallographic studies on 
(a)  Mor-DNA binary complex 
(b)  Mor-DNA-α-CTD ternary complex.  
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Appendix: Determining the effect of N- and C-terminal 
deletions of Mor 
 
 
In the Mor/C family of proteins the least conserved regions are the N-terminal and 
C-terminal portions of as shown in Figure 35. These are also the portions of Mor that are 
not visible in the crystal structure. It is important to note, however, that these sequences 
are not random; they simply show a smaller number of matches than the central region. 
Their potential importance to Mor function is underscored by the fact that deletion of the 
26 N-terminal or 9 C-terminal amino acids, not seen in the structure, render Mor non-
functional (Kumaraswami et al, 2004). Thus, the N- and C-terminal regions of Mor may 
be important for its structure and stability, binding to DNA or transcription activation 
through interactions with RNA polymerase. In order to determine the functional 
relevance of these terminal regions, serial deletions were made from both ends. For the 
N-terminus, 5, 10, 15, 20 and 25 amino acids were deleted and at the C-terminus, 3, 6, 9, 
12 and 15 amino acids were deleted. 
 
Primers with the above deletions were used in PCR reactions to create the deleted 
mor genes. Table 8 shows the sequences of the oligonucleotides that were used in this 
study. The N-terminal deletion primers retained the codon for the initiating methionine 
following the His-tag and the C-terminal deletion primers retained the stop codon. The 
deletion was made in two steps as shown in Figure 36: For the N-terminus, the top strand 
deletion primer was used with the bottom strand wild-type primer ZAO 3 in PCR 
amplification reaction to create PCR product 1. At the same time, the bottom strand 
primer with overlap to the N-terminal deletion primers was used with MUT 13 in a 
separate PCR reaction to create PCR product 2. The resulting PCR products 1 and 2 with 
overlapping ends were used as templates in another PCR reaction, and amplification was 
achieved using top and bottom strand wild-type primers, MUT 13 and ZAO 3, 
respectively. A similar strategy was used to make the C-terminal deletions with the 
difference that the deletion bottom-strand primers were used with MUT 13 for 
amplification, while the top strand overlap primer was used with ZAO 3. The PCR 
reaction combining the first two PCR products was similar to that for the N-terminal 
deletions. The template for the first and second PCR amplification reactions was the 
wild-type pIA69 which carries the his-mor gene under the influence of an IPTG-inducible 
PlacUV5 promoter. After purification of the final PCR products with a Qiaquick PCR 
purification kit, they were sequentially digested with NdeI and BamHI at 37°C for 3 
hours each. The digested products were again purified with a Qiaquick PCR purification 
kit and ligation reactions were set up with the similarly digested vector pIA69, and 
incubated at 16°C overnight. The ligation mixture was transformed into MH13435 
carrying the Pm-lacZ fusion plasmid pIA14. The resulting transformants were selected on 
MacConkey lactose indicator plates with 50 µM IPTG, chloramphenicol (25 μg/ml) and 
ampicillin (40 μg/ml); the promoter plasmid, pIA14 confers ampicillin resistance and the 
protein plasmid, pIA69 confers chloramphenicol resistance. Candidate clones were 
purified and sequenced to identify the deletions. The phenotypes resulting from the N- 
and C-terminal deletions are listed in Table 9.  
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Figure 35: Amino acid and secondary structure alignment for Mor and C proteins of 
bacteriophage Mu. 
 
α-helix is shown as an oval and β-strand as an arrow. Identical amino acids are shown in 
black boxes; chemically similar residues are shaded in gray. Dots indicate 10 amino acid 
intervals in Mor. 
 
Modified with permission from American Society for Biochemistry and Molecular 
biology. Kumaraswami M, Howe MM, Park HW. Crystal structure of the Mor protein of 
bacteriophage Mu, a member of the Mor/C family of transcription activators. J Biol 
Chem. 2004, 279(16): 16581-90. 
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Table 8: Oligonucleotides used for N- and C-terminal deletions of His-Mor. 
 
Primer Sequence (from 5’ to 3’ end) Comments 
 
KRI 1 GATGACGATAAGATG Δ 
GGTGATCTGCAGGATGACAC 
For deletion of 5 amino acids 
from the N-terminus of Mor. 
KRI 2 GATGACGATAAGATG Δ 
GACACCATCCTGGCACAT 
For deletion of 10 amino acids 
from the N-terminus of Mor. 
KRI 3 GATGACGATAAGATG Δ 
CATCTTGACAATCC 
For deletion of 15 amino acids 
from the N-terminus of Mor. 
KRI 4 GATGACGATAAGATG Δ 
GCCGAGGACACGTCACGCTTT 
For deletion of 20 amino acids 
from the N-terminus of Mor. 
KRI 20 GATGACGATAAGATG Δ 
CGCTTTCCGGCACTGCTGGCGGAG 
For deletion of 25 amino acids 
from the N-terminus of Mor. 
KRI 5 CATCTTATCGTCATCGTCGAG 
 
Bottom strand primer with 
overlapping region with  
N-terminal deletion primers. 
KRI 6 CGGCTTTACTGTTTA Δ 
GGGCTGGTACTGGCGGTA 
For deletion of 3 amino acids 
from the C-terminus of Mor. 
KRI 7 CGGCTTTACTGTTTA Δ 
CTGGCGGTATTTCA 
For deletion of 6 amino acids 
from the C-terminus of Mor. 
KRI 21 CGGCTTTACTGTTTA Δ 
TTTCAGCCGTCG 
For deletion of 9 amino acids 
from the C-terminus of Mor. 
KRI 22 CGGCTTTACTGTTTA Δ 
TCGCATGCGGCGAAT 
For deletion of 12 amino acids 
from the C-terminus of Mor. 
KRI 23 CGGCTTTACTGTTTA Δ 
GCGAATGGCTTTGTACACCGTA 
For deletion of 15 amino acids 
from the C-terminus of Mor. 
KRI 8 TAAACAGTAAAGCCGGTTAATCC 
 
Top strand primer with 
overlapping region with  
N-terminal deletion primers. 
MUT 13 CCAGGCTTTACACTTTATGC 
 
Wild-type top strand primer 
beyond 5’ end of mor gene. 
ZAO 3 ACCTGAAGTCAGCCCCATAC 
 
Wild-type bottom strand 
primer beyond 3’ end of mor 
gene. 
 
The oligonucleotide sequences are written from the 5’ to the 3’end.  
Δ indicates the position of the deletion from the mor gene. 
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Figure 36: Schematic diagram of the strategy used for deletion of amino acids from the 
N-terminus of Mor. 
 
The shaded block represents the part of pIA69 with the mor gene. The Δ shows the region 
of deletion. Layer I shows the position of the primers used for first set of amplification 
reactions. Layer II shows the products of the first two amplifications, their regions of 
overlap, and the region deleted. Layer III shows the final PCR product containing the 
deletion in the mor gene. 
 
 
 
 
 
 
Primer with N-terminal deletion 
Primer with overlap
MUT 13
ZAO  3
PCR product 1 
PCR product 2 
PCR product 3 with the deletion 
I
II
III
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Table 9: Resulting phenotypes of the N- and C-terminal deletion proteins. 
 
N-terminal 
deletions of Mor 
Phenotype of the 
colony with the 
deletion 
Δ 5 amino acids Red 
 
Δ 10 amino acids Red 
 
Δ 15 amino acids White 
 
Δ 20 amino acids White 
 
Δ 25 amino acids White 
 
 
 
 
C-terminal 
deletions of Mor 
Phenotype of the 
colony with the 
deletion 
Δ 3 amino acids Red 
 
Δ 6 amino acids Red 
 
Δ 9 amino acids White 
 
Δ 12 amino acids White 
 
Δ 15 amino acids White 
 
 
Δ indicates deletion. 
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Protein over-expression and small-scale protein purification for gel shift assay 
were performed as described in material and methods. Labeled probe was prepared using 
a γ-P32 labeled primer MLK 7 and unlabeled IRI 21 in a PCR reaction using pIA14, 
containing Pm sequences from -61 to +10 as template. The labeled probe was purified 
with a Qiaquick PCR purification kit. A 20 μl reaction volume containing about 50 
counts per second of radioactive probe, 50 ng of calf-thymus DNA, and different 
concentrations of the protein in binding buffer (20 mM Tris-HCl pH 7.9, 50 mM NaCl, 
5% glycerol and 1 mM DTT) was incubated at room temperature for 20 minutes. The 
reaction mixture was resolved on a 10% non-denaturing, native acrylamide gel containing 
0.5 X TBE and run in 0.5 X TBE buffer at 260 V for 3 hours at 4°C. Initial exposure of 
the gels to X-OMAT BioMax-MR films was done without drying. 
 
DNA-binding assays with the C-terminal deleted His-Mor proteins showed that 
proteins with Δ3C and Δ6C at the C-terminus retained DNA-binding ability correlating 
with their red colony phenotype. DNA-binding assay for Mor proteins carrying C-
terminal deletions is shown in Figure 37. Both Δ3C and Δ6C proteins bound the probe 
less than the wild-type and the Δ3C protein bound the probe less than Δ6C protein at both 
concentrations of protein used. For the two deletions and the wild-type, 800 ng of protein 
bound the probe more than 400 ng of the probe as indicated by the intensity of the shift. 
Δ9C, Δ12C and Δ15C did not bind the DNA probe at concentrations even as high as 800 
ng of His-Mor. Thus, the contribution by the last 6 amino acids of Mor is less critical 
than the others at the C-terminus as their deletion gave us functional protein in terms of 
binding to DNA as well as transactivation as indicated by red colony phenotype. It would 
be useful to investigate the importance of the amino acids at the C-terminus in terms of 
their contribution to Mor structure and function. 
 
An experiment was done to observe the shift by lower concentration of the 
protein. The gel shift for this experiment is shown in Figure 38. As observed previously, 
Δ6 C-terminus of His-Mor gave functional protein with respect to DNA-binding and 
hence activation determined by the red color of the colony. Δ6C bound the probe less 
than the wild-type. For Δ6C and the wild-type, the amount of probe bound to the protein 
gradually increases as the amount of protein increases in the reaction as indicated by the 
intensity of the shift. Δ6C bound the probe even at concentration as low as 200 ng of 
protein, but Δ9C did not bind the DNA probe at concentrations even as high as 800 ng of 
His-Mor. 
 
Similar to the C-terminus, DNA-binding experiments were done for proteins 
deleted from the N-terminus. DNA-binding assays with the deleted His-Mor proteins 
showed that proteins with Δ5N and Δ10N at the N-terminus retained DNA-binding 
ability consistent with their red colony phenotype. Both Δ5N and Δ10N proteins bound 
the probe less than the wild-type and Δ10N protein bound the probe more than Δ5N at 
both concentrations of protein used. For the two deletions and the wild-type, 800 ng of 
protein bound the probe more than 400 ng of the probe as indicated by the intensity of the 
shift. Δ15N, Δ20N and Δ25N did not bind the DNA probe at concentrations even as high 
as 800 ng of His-Mor. Thus, the contribution by the first 10 amino acids of Mor is less 
critical than the others at the N-terminus as their deletion gave us functional protein in  
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Figure 37: Gel shift for Mor proteins carrying C-terminal deletions. 
 
 
 
 
 
Figure 38: Gel shift for Δ6C and Δ9C Mor proteins. 
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terms of binding to DNA as well as transactivation as indicated by red colony phenotype. 
DNA-binding assay for Mor proteins carrying N-terminal deletions is shown in Figure 
39. It would be useful to investigate the importance of the amino acids at the N-terminus 
in terms of their contribution to Mor structure and function.  
 
 An experiment was done to observe the shift by lower concentration of the 
protein. The gel shift for this experiment is shown in Figure 40. As observed previously, 
Δ10N of His-Mor gave functional protein with respect to DNA-binding and hence 
activation determined by the red color of the colony. Δ10N bound the probe less than the 
wild-type. For Δ10N and the wild-type, the amount of probe bound to the protein 
gradually increases as the amount of protein increases in the reaction as indicated by the 
intensity of the shift. Δ10N bound the probe even at concentration as low as 200 ng of 
protein, but Δ15N did not bind the DNA probe at concentrations even as high as 800 ng 
of His-Mor. 
 
It was observed reproducibly in the N-terminal deletion and C-terminal deletion 
gels that a band appeared as the number of amino acid deleted increased. So, an 
experiment was done to test if any other proteins from the cell supernatant bind the DNA 
probe and result in a shift in the probe. A constant amount of wild-type His-Mor (400 ng) 
was used with increasing amount of cell supernatant. The supernatents were from a strain 
that did not have his-mor gene in its plasmid. Since there are no additional bands that 
appear to be shifted with concentrations as high as 6400 ng of the supernatant used, it 
could be concluded that no other protein from the cell supernatant fraction other than His-
Mor bound the probe as seen in Figure 41. 
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Figure 39: Gel shift for Mor proteins carrying N-terminal deletions. 
 
 
 
 
Figure 40: Gel shift for Δ10N and Δ15N Mor proteins. 
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Figure 41: Gel shift with increasing amounts of supernatant. 
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